Page last updated: 2024-08-16

rivastigmine and donepezil

rivastigmine has been researched along with donepezil in 448 studies

Research

Studies (448)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (2.23)	18.2507
2000's	200 (44.64)	29.6817
2010's	168 (37.50)	24.3611
2020's	70 (15.63)	2.80

Authors

Authors	Studies
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X	1
Alley, GM; Brossi, A; Deschamps, JR; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, D; Yu, QS; Zhan, M	1
Hu, Y; Jiang, Y; Li, J; Lin, X; Shang, Z; Sheng, R	1
Brossi, A; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, DA; Shafferman, A; Tweedie, D; Yu, QS	1
Andrisano, V; Banzi, R; Bartolini, M; Bergamini, C; Bolognesi, ML; Cattaneo, A; Cavalli, A; Fato, R; Hrelia, P; Lenaz, G; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tarozzi, A; Tumiatti, V	1
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V	1
He, Q; Hu, C; Hu, Y; Li, J; Lin, X; Sheng, R; Xu, Y; Yang, B; Zhang, J	1
Chol, KS; He, Q; Hu, Y; Huang, W; Lin, X; Sheng, R; Yang, B; Zhang, J	1
Chaudhaery, SS; Nath, C; Nazir, A; Roy, KK; Sammi, SR; Saxena, AK; Saxena, G; Shakya, N	1
Al-Rashid, ZF; Hsung, RP	1
Boido, V; Carotti, A; Catto, M; Giangreco, I; Nicolotti, O; Novelli, F; Pisani, L; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M	1
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP	1
Bazureau, JP; Burgy, G; Carreaux, F; Cochet, C; Delhommel, F; Durieu, E; Elkins, JM; Filippakopoulos, P; Knapp, S; Lo, DC; Meijer, L; Oberholzer, AE; Pearl, LH; Schmid, RS; Soundararajan, M; Tahtouh, T	1
Carotti, A; Catto, M; Cellamare, S; Leonetti, F; Nicolotti, O; Pesce, P; Pisani, L; Stefanachi, A	1
Bellman, K; Knegtel, RM; Settimo, L	1
Arán, VJ; Campillo, NE; Fernández-Ruiz, J; García-Arencibia, M; Girón, R; Gómez-Cañas, M; González-Naranjo, P; Martín, MI; Páez, JA; Pérez, C; Pérez-Macias, N; Sánchez-Robles, E	1
Adam, BL; Gao, J; Terry, AV	1
Hu, Y; Li, Y; Peng, P; Sheng, R; Tang, L	1
Ang, W; Deng, Y; Li, Y; Liu, Q; Luo, Y; Qiang, X; Sang, Z; Shi, Y; Tan, Z; Yuan, W	1
Amooru, GD; Ampasala, DR; Darla, MM; Devineni, SR; Eadlapalli, S; Kotapati, KV; Palaka, BK; Penumala, M; Shaik, JB; Vadde, R	1
Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Tan, Z; Xiao, G; Yang, X	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hoda, N; Jameel, E; Jayaram, B; Kumar, J; Maqbool, M; Meena, P; Mobashir, M; Shandilya, A; Singh, A; Tiwari, M	1
Aitken, L; Benek, O; Dohnal, V; Dolezal, R; Guest, P; Gunn-Moore, F; Hroch, L; Janockova, J; Kuca, K; Musil, K; Musilek, K; Smith, TK; Soukup, O	1
Brazzolotto, X; Chan, S; De la Mora, E; Deora, GS; Dighe, SN; Nachon, F; Parat, MO; Ross, BP	1
Bajda, M; Gobec, S; Godyń, J; Janockova, J; Jończyk, J; Knez, D; Korabecny, J; Malawska, B; Mika, K; Panek, D; Soukup, O; Wichur, T; Więckowska, A	1
Chen, J; Chen, Q; Chen, Z; Chu, J; Digiacomo, M; Gu, Q; Han, Y; Macchia, M; Nesi, G; Pi, R; Rapposelli, S; Sestito, S; Tu, Y; Wang, S; Yang, X	1
Azzouz, R; Bohn, P; Gembus, V; Levacher, V; Papamicaël, C; Peauger, L; Sopková-de Oliveira Santos, J; Ţînţaş, ML	1
Andrisano, V; Apperley, KYP; Bartolini, M; Baschieri, A; Basso, M; Chen, HH; De Simone, A; Guardigni, M; Keillor, JW; Kobrlova, T; Milelli, A; Montanari, S; Soukup, O; Valgimigli, L	1
Chen, Q; Digiacomo, M; Nesi, G; Pi, R; Rapposelli, S; Sestito, S; Wang, S; Yang, X	1
Brazzolotto, X; Brus, B; Colletier, JP; Coquelle, N; Gobec, S; Jukič, M; Knez, D; Kos, J; Košak, U; Nachon, F; Pišlar, A; Podkowa, A; Sałat, K; Šink, R; Stojan, J; Trontelj, J; Žakelj, S; Živin, M	1
Brazzolotto, X; Colletier, JP; Coquelle, N; Gobec, S; Jukič, M; Knez, D; Kos, J; Mravljak, J; Nachon, F; Pišlar, A; Sova, M; Žakelj, S	1
Cao, Z; Deng, Y; Li, Y; Liu, H; Qiang, X; Song, Q; Tan, Z; Tian, C; Yang, Z	1
Campillo, NE; de Ceballos, ML; Girón, R; González-Naranjo, P; Martín-Fontelles, MI; Martin-Requero, A; Páez, JA; Pérez, C; Pérez-Macias, N; Roca, C; Sánchez-Robles, E; Vaca, G	1
Kumar, A; Mishra, P; Panda, G	1
Abu-Serie, MM; AlFadly, ED; Bakkar, NZ; Bartolini, M; Belal, ASF; El-Yazbi, AF; Elkazaz, S; Elzahhar, PA; Ghareeb, DA; Iriepa, I; Janockova, J; Kobeissy, F; Moraleda, I; Rafeh, RW; Saudi, MNS; Shaltout, H; Soukup, O; Tramarin, A	1
Krishnamurthy, S; Prajapati, SK; Seth, A; Sharma, P; Shrivastava, SK; Srivastava, P; Tiwari, V; Tripathi, A; Tripathi, MK; Tripathi, PN	1
Chen, C; Fu, J; Hu, M; Li, X; Shao, S; Shi, G; Wang, D; Wu, S; Zhang, D; Zhang, T; Zhou, Y	1
Bolognesi, ML; da Costa Nunes, JL; de Oliveira Miranda, C; de Oliveira, AS; Gandini, A; Gervasoni, S; Jung, M; Kobrlova, T; Massenzio, F; Monti, B; Petralla, S; Rossi, M; Senger, J; Simões Heyn Roth Cardoso, G; Soares Romeiro, LA; Soukup, O; Vistoli, G	1
Liu, W; Sang, Z; Shi, J; Tan, Z; Wang, K	1
Liu, W; Sang, Z; Shi, J; Tan, Z; Wang, K; Zhang, P	1
Alsulami, H; Chen, X; Jiang, X; Qin, HL; Tang, W; Wang, Z; Xu, Y; Zhang, Z	1
Choubey, PK; Krishnamurthy, S; Prajapati, SK; Seth, A; Sharma, P; Shrivastava, SK; Tripathi, A; Tripathi, MK; Tripathi, PN	1
do Carmo Carreiras, M; Ismaili, L; Marco-Contelles, J	1
Cheng, X; Liu, W; Ma, Q; Sang, Z; Shi, J; Tan, Z; Wang, K; Wei, R; Yu, L; Zhao, Y; Zhu, G	1
Cheng, X; Liu, W; Qiao, Z; Sang, Z; Shi, J; Tan, Z; Wang, K; Wang, Y; Wu, A; Zhao, Y; Zhu, G	1
Bai, P; Chen, Z; Lan, Y; Liu, W; Qiao, Z; Sang, Z; Shi, J; Tan, Z; Wang, C; Wang, K; Wang, Y; Wu, A; Zhao, Y; Zhu, G	1
Cui, Z; Gao, J; Geng, H; Li, D; Li, H; Zhou, B; Zhou, L	1
Chen, M; Jiang, X; Min, J; Qin, H; Tang, W; Xu, Y; Zhang, Z	1
Benek, O; Benkova, M; Dolezal, R; Hepnarova, V; Hrabinova, M; Janockova, J; Jun, D; Kobrlova, T; Korabecny, J; Kucera, T; Mezeiova, E; Prchal, L; Sobolova, K; Soukup, O	1
Brogi, S; Gabr, MT	1
Choubey, PK; Sharma, P; Shrivastava, SK; Tripathi, A	1
Boulouard, M; Claeysen, S; Corvaisier, S; Dallemagne, P; Davis, A; Freret, T; Hatat, B; Lalut, J; Lecoutey, C; Rochais, C; Since, M; Sopková-de Oliveira Santos, J; Toublet, FX	1
Andrys, R; Capek, J; Handl, J; Hrabinova, M; Janockova, J; Kobrlova, T; Korabecny, J; Marco-Contelles, JL; Mezeiova, E; Micankova, P; Muckova, L; Nepovimova, E; Pejchal, J; Rousar, T; Simunkova, M; Soukup, O; Valko, M	1
Cao, Z; Cong, S; Deng, Y; Liu, Z; Song, Q; Tan, Z; Yu, G	1
Diao, XX; Gan, HX; Huang, J; Huang, Y; Li, J; Ma, L; Sun, JM; Tang, Y; Wang, R; Yang, GX; Zhang, L; Zheng, LL	1
Chowdhury, SR; Fu, L; Gu, J; Hu, Y; Jiang, F; Lam, C; Lei, S; Lu, D; Tavallaie, MS; Wang, J	1
Jiang, X; Liu, XH; Shi, J; Tang, W; Wang, S; Wu, C; Xu, Y; Zha, L; Zhang, J; Zhang, Z; Zuo, J	1
Brazzolotto, X; Bucki, A; Gobec, S; Godyń, J; Góral, I; Głuch-Lutwin, M; Honkisz-Orzechowska, E; Knez, D; Kołaczkowski, M; Latacz, G; Malawska, B; Panek, D; Pasieka, A; Sabate, R; Siwek, A; Wichur, T; Więckowska, A	1
Deng, Y; Liu, X; Liu, Z; Shi, Y; Song, Q; Tan, Z; Yu, G; Zhang, H; Zhong, F	1
He, Y; Liu, W; Mi, J; Sang, Z; Wu, A; Yang, J; Zhou, Y; Zhu, G	1
Bayomi, SM; El-Subbagh, HI; Ghaly, MA; Saad, KM; Waly, OM	1
Palacios, JM	1
Schneider, LS	2
Honma, A	1
Lacomblez, L	1
Derquesné, C	1
Dom, R; Lemière, J; Van Gool, D	1
Kosasa, T; Kuriya, Y; Matsui, K; Yamanishi, Y	2
Kosasa, T; Kuriya, Y; Yamanishi, Y	1
Burns, A; Page, S; Russell, E	1
Baik, J; Han, IW; Koo, MS; Kwak, YT	1
Stahl, SM	2
Dronfield, S; Egan, K; Green, AR; Marsden, CA	1
Giacobini, E	1
Grutzendler, J; Morris, JC	1
Kosasa, T; Kuriya, Y; Ogura, H; Yamanishi, Y	1
Bryant, J; Clegg, A; De Broe, S; Gerard, K; McIntyre, L; Nicholson, T; Waugh, N	2
Farlow, MR	2
Hake, AM	1
Lampley-Dallas, VT	1
Gavrilova, SI; Zharikov, GA	1
Slagle, MA	1
Amici, S; Antognelli, C; Gallai, V; Lanari, A; Parnetti, L; Romani, R	1
Winblad, B	1
Sternon, J; Ventura, M	1
Gasser, T; Schreiter Gasser, U	1
Gasser, T; Gasser, US	1
Bullock, R; Connolly, C	1
Allain, H; Bentue-Ferrer, D; Lecavorzin, P; Polard, E; Reymann, JM; Tribut, O	1
Klein, C; Rabey, JM; Werber, AE	1
Cherry, D; Cummings, JL; Frank, JC; Hewett, L; Kemp, B; Kohatsu, ND; Mittman, B	1
Auriacombe, S; Loria-Kanza, Y; Pere, JJ; Vellas, B	1
Robert, P	1
Blount, PJ; McDeavitt, JT; Nguyen, CD	1
Bellucci, A; Casamenti, F; Costagli, C; Pepeu, G; Scali, C; Schmidt, B	1
Demers, L; Momoli, F; Moride, Y; Oremus, M; Perrault, A; Shukla, V; Wolfson, C	1
Rösler, M	1
Inglis, F	1
Jann, MW; Shirley, KL; Small, GW	1
Darcourt, J; Ebmeier, K; Koulibaly, M; Mariani, G; Migneco, O; Nobili, F; Pupi, A; Robert, PH; Rodriguez, G; Vitali, P	1
Ott, BR	1
Kim, JM; Shin, IS; Yoon, JS	1
Anderson, DM; Hoehns, JD; Taylor, AM; Tobert, DG	1
Howard, R; Sauer, J	1
Castro, A; Martinez, A	1
McRae, TD; Schwam, EM	1
Tang, XC; Zhao, Q	1
Järvenpää, T; Kaasinen, V; Kurki, T; Någren, K; Oikonen, V; Rinne, JO; Roivainen, A; Yu, M	1
Kamei, H; Nabeshima, T; Noda, Y	1
Amici, S; Andreasen, N; Antognelli, C; Blennow, K; Davidsson, P; Gallai, V; Lanari, A; Minthon, L; Parnetti, L; Pottel, H; Romani, C	1
Hartmann, S; Möbius, HJ	1
Adler, G; Berger, FM; Calabrese, P; Frölich, L; Gertz, HJ; Hampel, H; Haupt, M; Jendroska, K; Kohler, J; Mielke, R; Paulus, HJ; Pilartz, H; Riepe, MW; Zedlick, D	1
Farlow, M	1
Albuquerque, EX; Christner, C; Fehrenbacher, A; Höffle, A; Jostock, R; Lübbert, H; Ludwig, J; Maelicke, A; Pereira, EF; Radina, M; Samochocki, M; Ullmer, C; Zerlin, M	1
Gandelman-Marton, R; Klein, C; Rabey, JM; Werber, EA	1
Akkawi, N; Bordonali, T; Borroni, B; Di Luca, M; Padovani, A; Pettenati, C	1
Bianchetti, A; Rozzini, R; Trabucchi, M	1
Gray, R	1
Doody, RS	1
Butler, R; Prabhakaran, P; Warner, J	1
Bonelli, RM	1
Fuchsberger, T; Hampel, H; Möller, HJ	1
Baezner, H; Daffertshofer, M	1
Alhainen, K	1
Adler, G; Brassen, S	1
Kaufer, DI	2
Bullock, R; Emre, M; Farlow, MR; Gauthier, S; Grossberg, GT; Potkin, SG	1
Auriacombe, S; Pere, JJ	1
Haen, E; Ibach, B	1
Alisky, JM	1
Erkinjuntti, T; Feldman, H; Gauthier, S; Rockwood, K; Román, G	1
Liang, YQ; Tang, XC	2
Bardelli, F; Bencini, F; Biagini, CA; Caleri, V; Cantini, C; Cavallini, MC; Marini, M; Masotti, G; Mecacci, R; Mossello, E; Razzi, E; Sarcone, E; Tilli, S; Tonon, E	1
Prasher, VP	1
Birks, J; Evans, JG; Wilcock, G	1
Kurz, A; Van Baelen, B	1
van Dyck, CH	1
Herrmann, N; Lanctôt, KL; Thompson, S	1
Lampl, Y; Lorberboym, M; Sadeh, M	1
Caricati-Neto, A; D'angelo, LC; Garcia, AG; Hyppolito Jurkiewicz, N; Jurkiewicz, A; Reuter, H	1
Edwards, K; Gorman, C; Therriault O'connor, J	1
Aguglia, E; Maso, E; Onor, ML; Saina, M	1
Erkinjuntti, T; Gauthier, S; Román, G	1
Arcona, S; Beusterien, KM; Gause, D; Kimel, M; Mirski, D; Thomas, SK	1
Tenovuo, O	1
Simard, M; van Reekum, R	1
Cruz-Jentoft, AJ; del Ser, T; Fernández-Bullido, Y; Frank, A; Galiano, M; García de la Rocha, ML; González-Salvador, MT; Muñiz, R; Navarro, E; Olazarán, J; Peña-Casanova, J; Reisberg, B; Serra, JA; Serrano, P; Sevilla, C	1
Arya, P; Butler, R; Warner, J	2
Abramowski, D; De Deyn, PP; Staufenbiel, M; Van Dam, D	1
Garre-Olmo, J; Gelada-Batlle, E; Hernández-Ferràndiz, M; Isern-Vila, A; López-Pousa, S; Lozano-Gallego, M; Majó-Llopart, J; Morante-Muñoz, V; Pericot-Nierga, I; Turon-Estrada, A; Vilalta-Franch, M	1
Alwahhabi, FK	1
Kmietowicz, Z	1
Lee, WC; Mauskopf, JA; Paramore, C; Snyder, EH	1
Ellis, JM	1
Caffari, B; Maggini, M; Martini, N; Raschetti, R; Sorrentino, GC; Vanacore, N	1
Bullock, R; Dengiz, A	1
Cummings, JL	1
Borkowska, A; Rybakowski, JK; Ziolkowska-Kochan, M	1
Aisen, PS	1
Arcona, S; Suh, DC; Thomas, SK; Valiyeva, E; Vo, L	1
Beck-Bornholdt, HP; Kaduszkiewicz, H; van den Bussche, H; Zimmermann, T	1
Bergman, H; Bullock, R; Gambina, G; He, Y; Lane, R; Nagel, J; Rapatz, G; Touchon, J	1
Arcona, S; Lingala, V; Mithal, A; Singh, G; Thomas, SK	1
Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M	1
O'Neill, MF	1
Lublin, HK; Olsen, CE; Poulsen, HD	1
Jelic, V; Kivipelto, M; Winblad, B	1
Clegg, A; Green, C; Kirby, J; Loveman, E; Payne, E; Picot, J; Takeda, A	2
Burns, A; Olde Rikkert, MG; Oude Voshaar, RC	1
Davis, B; Sadik, K	1
Bergman, H; Bullock, R; Lane, R; Nagel, J; Rapatz, G; Touchon, J	1
Birks, J	1
Abdullah, L; Crowell, TA; Mullan, M; Paramadevan, J	1
Kuo, SC; Lin, SJ; Yang, YH	1
Bergman, H; Bullock, R; Gambina, G; He, Y; Lane, R; Nagel, J; Touchon, J	1
Doganay, G; Georgiou, G; Khalil, Z; Khodr, B	1
Butler, R; Warner, J; Wuntakal, B	1
Cummings, JL; Ringman, JM	1
Bernardini, S; Bonuccelli, U; Ceravolo, R; Frosini, D; Kiferle, L; Logi, C; Manca, G; Mariani, G; Murri, L; Rossi, C; Volterrani, D	1
Nourhashémi, F	1
Gilbert, S; Kergoat, MJ; Kerneis, S; Legrain, S; Vantelon, C; Wolmark, Y	1
Dybicz, SB; Erwin, WG; Keohane, DJ; McRae, T; Shah, SN	1
Ancoli-Israel, S; Cooke, JR; Corey-Bloom, J; Fiorentino, L; Harrison, T; Liu, L; Loredo, JS; Marler, M	1
Blennow, K; de Leon, MJ; Zetterberg, H	1
Verhey, FR	1
Johannsen, P	1
Bergman, H; Blesa, R; Bullock, R; Gambina, G; He, Y; Lane, R; Meyer, J; Nagel, J; Rapatz, G	1
Geyer, H; Schänzer, W; Thevis, M; Wilkens, F	1
Ieni, J; Maurice, T; Meunier, J	1
Schneeweiss, S; Thacker, EL	1
Chilovi, BV; Costardi, D; Franzoni, S; Padovani, A; Rozzini, L; Trabucchi, M	1
Agbokou, C; Ferreri, F; Gauthier, S	1
Bhasin, M; Edwards, K; McKeith, I; Rowan, E	1
Campanozzi, MD; Casali, E; Martini, E; Neri, M; Neviani, F	1
Gruber, J; Hollenack, K; O'Shea, T; Stefanacci, R; Tangalos, EG; Zarowitz, BJ	1
Agrawal, R; Nath, C; Shukla, R; Tyagi, E	1
Aerssens, J; Alvidrez, J; Anand, R; Faison, WE; Farrer, LA; Jarvik, L; Manly, J; McRae, T; Mintzer, JE; Murphy, GM; Olin, JT; Regier, D; Sano, M; Schultz, SK	1
Starr, JM	1
Ballard, CG; Chalmers, KA; Love, S; McKeith, IG; O'Brien, JT; Perry, EK; Todd, C; Wilcock, G	1
Egert, S; Förstl, H; Wagenpfeil, S	1
Anderson, KE; Bell, K; Brickman, AM; Flynn, J; Marder, KS; Moeller, JR; Sackeim, H; Scarmeas, N; Stern, Y; Van Heertum, R	1
Basun, H; Cederholm, T; Eriksdotter-Jönhagen, M; Faxén-Irving, G; Freund-Levi, Y; Garlind, A; Grut, M; Palmblad, J; Vedin, I; Wahlund, LO	1
Bonham, J; Connelly, PJ; Cousland, G; Prentice, NP	1
Cerbai, F; Enz, A; Giovannini, MG; Melani, C; Pepeu, G	1
Baker, AS; Brandt, J; Lyketsos, CG; Mayer, LS; McNabney, M; Onyike, CU; Rosenblatt, A; Samus, QM	1
Caffarra, P; Copelli, S; Dieci, F; Messa, G; Nonis, E; Venneri, A; Vezzadini, G	1
Kavirajan, H; Schneider, LS	1
Anghelescu, I; Heuser, I	1
Green, C	1
McCain, KR; Sawyer, TS; Spiller, HA	1
Neno, R	1
Lang, CJ	1
Kircher, T; Leucht, S; Thienel, R; Voss, B	1
Bagheri, H; Lapeyre-Mestre, M; Montrastruc, JL; Sommet, A; Tavassoli, N	1
Bajda, M; Malawska, B; Musiał, A	1
Bogetto, F; Marino, F; Montemagni, C; Perrone, D; Rocca, P	1
Gorelick, PB; Nyenhuis, DL	1
Landmark, K; Reikvam, A	1
Adelman, A; Campos-Outcalt, D; Cross, JT; Forciea, MA; Hopkins, R; Mehr, D; Owens, DK; Qaseem, A; Santaguida, P; Schellhase, K; Shekelle, P; Snow, V	1
Booker, L; Cowan, D; Ismaila, A; Levine, M; Oremus, M; Patterson, C; Raina, P; Santaguida, P	1
Downey, D	1
Lonie, J; Starr, JM	1
Liao, S; Morrison, LJ	1
Shimohama, S	2
Graham, L	1
Dartigues, JF; Fourrier-Réglat, A; Helmer, C; Merliere, Y; Moore, N; Pariente, A	1
Graham, K; Josif, S	1
Cuffel, B; Del Valle, M; Mark, TL; McRae, T; Mucha, L; Shaohung, S	1
Gartlehner, G; Hansen, RA; Jonas, DE; Moore, CG; Morgan, LC; Webb, AP	1
Reid, RT; Sabbagh, MN	1
Corbo, RM; Gambina, G; Moretto, G; Scacchi, R	1
Ruis, J	1
Feldman, HH; Hsiung, GY	1
Boucher, JM; Charbonneau, C; Dorais, M; LeLorier, J; Lescrauwaet, B; Massoud, F	1
Darreh-Shori, T; Eagle, G; Lane, R; Mousavi, M; Nordberg, A; Peskind, E; Soininen, H	1
Blais, L; Forget, A; Kergoat, MJ; Kettani, FZ; Leroux, JC; Perreault, S	1
Jurivich, DA; Patel, AR; Perez, F; Zhou, X	1
Ehret, A; Feuerstein, TJ; Förster, S; Jackisch, R; Kammerer, M; Rothmaier, AK; Zentner, J	1
Crutchfield, D	1
Smith, DA	1
Lane, R; Venneri, A	1
Duysen, EG; Hartmann, J; Kiewert, C; Klein, J; Lockridge, O; Naik, RS	1
Bullock, R; Hatoum, HT; Lane, R; Lin, SJ; Thomas, SK	1
Morgan, S; Rodda, J; Walker, Z	1
Binder, C; Camacho, F; Dalziel, W; Herrmann, N; Smyth, S	1
Tang, XC; Wang, J; Zhang, HY	1
Dominguez, J; Gauthier, S; Homma, A; Ikeda, M; O'Connor, D; Suh, GH; Wimo, A; Yang, BM	1
Alfonso, V; González-Adalid, M; Jiménez Caballero, PE; Sevilla, C	1
Adler, M; Akkerman, M; Albuquerque, EX; Aracava, Y; Pereira, EF	1
Bakar, M; Gumustas, O; Parlayan, E; Yulug, B	1
Cantor, MD; Farwell, W; Hernandez, RK; Lawler, EV	1
Kelly, S; Lockhart, IA; Mitchell, SA	1
Alva, G; Farlow, MR; Meng, X; Olin, JT	1
Bouchard, RW; Goodman, I; Perez, JA; Sadowsky, C; Tekin, S	1
Bagnoli, S; Bellavista, E; Benussi, L; Binetti, G; Chiamenti, AM; Crepaldi, G; Cruciani, G; Di Iorio, A; Feraco, E; Franceschi, C; Gabelli, C; Ghidoni, R; Gianni, W; Ginestroni, A; Grimaldi, LM; Marchegiani, F; Minicuci, N; Mishto, M; Nacmias, B; Olivieri, F; Paganelli, R; Santoro, A; Scarpino, O; Scognamiglio, M; Siviero, P; Sorbi, S	1
Farlow, MR; Meng, X; Olin, JT; Sadowsky, CH	1
Calciano, MA; Einstein, R; Snyder, PJ; Zhou, W	1
Heuser, I; Laisney, O; Repantis, D	1
Formiga, F; Fort, I; Regalado, P; Robles, MJ; Rodriguez, D	1
Gadzhanova, S; Mackson, J; Roughead, L	1
Londos, E; Minthon, L; Wallin, AK; Wattmo, C	1
Mimica, N; Presecki, P	1
Borah, B; Sacco, P; Zarotsky, V	1
Criado-Alvarez, JJ; Romo Barrientos, C	1
Attard, A; Jacobsen, P; Patel, SS; Shergill, S	1
Appelt, DM; Balin, BJ; Galluzzi, KE	1
Deuschl, G; Förstl, H; Mollenhauer, B; Oertel, W; Storch, A; Trenkwalder, C	1
Duh, MS; Kahler, KH; Lefebvre, P; Mody-Patel, N; Scharre, DW; Vekeman, F	1
Desmarais, JE; Gauthier, S; Massoud, F	1
Mets, T; Van Puyvelde, K	1
Kinnair, D; Machili, C; Prettyman, R; Van Diepen, E	1
Landau, R	1
Hüll, M; Voigt-Radloff, S	1
Bohlken, J; Selke, GW; van den Bussche, H	1
Kremer, J	1
Barbujani, G; Chianella, C; Fuselli, S; Gragnaniello, D; Maisano Delser, P; Sette, E; Tola, MR; Visentini, MF	1
Barone, E; Butterfield, DA; Mancuso, C; Preziosi, P; Siciliano, R	1
Alkam, T; Furukawa-Hibi, Y; Greig, NH; Matsuyama, A; Mizoguchi, H; Moussaoui, S; Nagai, T; Nitta, A; Suzuki, K; Yamada, K; Yu, QS	1
Jagiella, J; Klimkowicz-Mrowiec, A; Marona, M; Slowik, A; Spisak, K; Szczudlik, A; Wolkow, P	1
Okochi, M; Takeda, M; Tanaka, T	1
Anderson, G; Austin, PC; Gill, SS; Gruneir, A; Reimer, CL; Rochon, PA; Seitz, DP	1
Guo, D; Hao, Z; He, D; Wu, B; Zhou, H	1
Caraci, F; Drago, F; Fedotova, J; Leggio, GM; Salomone, S	1
Grasing, K; He, S; Yang, Y	1
Atri, A	1
Jayaram, MB; Kour, K; Singh, J	1
Leelavathi, M; Rosdinom, R; Suguna, M	1
Aisen, PS; Cummings, J; Schneider, LS	1
Ansermot, N; Dobrinas, M; Eap, CB; Noetzli, M	1
Gray, SL; McDermott, CL	1
Fox, C; Maidment, I; McShane, R; Rolinski, M	1
Isaac, M; Klugman, A; Naughton, DP; Petroczi, A; Shah, I; Tabet, N	1
Dawid-Milner, MS; Gormaz, I; Martin, I; Mendez, L; Ojea, T; Perez, A; Rojas, F; Sanchez-Siles, JM; Tamimi, F; Tamimi, I	1
Anderson, R; Bond, M; Davis, S; Hoyle, M; Hyde, C; Jeffreys, M; Miners, A; Moxham, T; Peters, J; Rogers, G; Thokala, P; Wailoo, A	1
Ateskan, U; Bozoglu, E; Isik, AT; Soysal, P; Yay, A	1
Minthon, L; Wallin, AK; Wattmo, C	2
Chen, SH; Lin, SJ; Lu, CY; Wang, YR; Yang, YH	1
Eap, CB; Noetzli, M	1
Adorni, F; Caltagirone, C; Di Santo, SG; Musicco, M; Prinelli, F	1
Johnell, K; Sonde, L	1
Gard, PR; Isaac, M; Klugman, A; Richardson, C; Tabet, N	1
Londos, E; Minthon, L; Paulsson, E; Wattmo, C	1
Peters, KR	1
Arizaga, RL; Demey, I; Rojas, G	1
Farlow, M; Ferris, SH	1
Ashoor, HM; Berliner, S; Chen, MH; Hemmelgarn, B; Ho, JM; Ng, CH; Soobiah, C; Straus, SE; Tricco, AC	1
Broggio, E; Corbo, RM; Gambina, G; Scacchi, R	1
Cumbo, E; Ligori, LD	1
Dong, S; Gao, X; He, D; Wang, D; Zhang, Y; Zhou, H	1
Mullangi, R; Ponnayyan Sulochana, S; Sharma, K; Sukumaran, SK	1
Braund, V; DesLauris, C; Leikin, JB	1
Hartikainen, S; Koponen, M; Taipale, H; Tanskanen, A; Tiihonen, J; Tolppanen, AM	1
Castagna, A; Cotroneo, AM; De Palo, G; Fabbo, A; Forgione, L; Gareri, P; Giacummo, A; Lacava, R; Marino, S; Putignano, D; Putignano, S; Simone, M; Zurlo, A	1
Jiang, T; Meng, XF; Tan, CC; Tan, L; Tan, MS; Wang, C; Wang, HF; Yu, JT; Zhu, XC	1
Gawel, K; Jenda, M; Kotlinska, JH; Labuz, K; Silberring, J	1
Shoji, M	1
Akaishi, T	1
Utsumi, K	1
Fujii, M; Sasaki, H	1
Ahnaou, A; Drinkenburg, WH; Huysmans, H; Jacobs, T	1
Cascavilla, L; D'Onofrio, G; Fontana, A; Gravina, C; Greco, A; Paroni, G; Pellegrini, F; Pilotto, A; Seripa, D; Urbano, M	1
Eichler, T; Hertel, J; Hoffmann, W; Kilimann, I; Michalowsky, B; Teipel, S; Thyrian, JR; Wucherer, D	1
Darreh-Shori, T; Lane, RM	1
Bozoglu, E; Cintosun, U; Doruk, H; Kocak, N; Naharci, MI; Ozturk, A; Tasci, I; Yasar, H	1
Kaddoumi, A; Mohamed, LA; Qosa, H	1
Hsieh, CY; Iwata, I; Kao Yang, YH; Lai, EC; Setoguchi, S; Wong, MB; Zhang, Y	1
Huang, AR; Redpath, CJ; van Walraven, C	1
Heinrich, S; Hertel, J; Hoffmann, W; Meyer, S; Michalowsky, B; Schaefer-Walkmann, S; Thyrian, JR; Wübbeler, M; Wucherer, D	1
Chou, YJ; Chow, LH; Hu, HY; Huang, N; Li, CP; Wang, PN; Wu, CY	1
Chamberlin, KW; Ehret, MJ	1
Berkers, M; Carmichael, PH; Egberts, T; Kröger, E; Laroche, ML; Mouls, M; Souverein, P; van Marum, R; Wilchesky, M	1
Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Matsuzono, K; Nakano, Y; Ohta, Y; Sato, K; Yamashita, T	2
Ransmayr, G	1
Aref, H; Bassil, N; diTommaso, S; Kandiah, N; Lee, JH; Pai, MC; Srinivasan, AV; Yuksel, O	1
Abagyan, R; Ali, TB; Chen, WY; Reilly, BM; Schleret, TR	1
Lewis, SJ; Szeto, JY	1
Kobayashi, H; Nakagawa, R; Ohnishi, T; Yoshizawa, K	1
Bezerra da Silva, C; Dalarmi, L; Dallarmi Miguel, M; de Fátima Gaspari Dias, J; de Oliveira, M; Elifio-Esposito, S; Fialho do Nascimento, K; Gomes Miguel, O; Moura Burci, L; Pott, A; Warumby Zanin, SM	1
Gruca, P; Lason-Tyburkiewicz, M; Papp, M; Willner, P	1
Confaloni, A; Tata, AM; Tosto, G	1
Chen, YD; Hu, WL; Wang, Y; Yuan, JL; Zhang, J	1
Cantrell, FL; Pchelnikova, JL; Thornton, SL	1
Isik, AT; Soysal, P	1
Caporaso, R; Minarini, A; Rosini, M; Simoni, E	1
Gawel, K; Gibula-Bruzda, E; Jenda, M; Kotlinska, JH; Labuz, K; Marszalek-Grabska, M; Silberring, J	1
Matsuda, T	1
Filarowska, J; Gawel, K; Gibula-Bruzda, E; Jenda, M; Kotlinska, JH; Labuz, K; Marszalek-Grabska, M; Silberring, J	1
Deardorff, WJ; Grossberg, GT	1
Fišar, Z; Hroudová, J; Singh, N	1
Hartikainen, S; Lampela, P; Lavikainen, P; Taipale, H; Tanskanen, A; Tiihonen, J; Tolppanen, AM	1
Dziedzic, M; Gawel, K; Gibula-Bruzda, E; Jenda-Wojtanowska, M; Kotlinska, JH; Marszalek-Grabska, M; Silberring, J	1
Abe, K; Darwish, M; Hishikawa, N; Ohta, Y; Sato, K; Takemoto, M; Yamashita, T	1
Bassett, K; Carney, G; Dormuth, CR; Fisher, A	1
Abe, K; Fukui, Y; Hishikawa, N; Ichinose, J; Morihara, R; Nakano, Y; Ohta, Y; Sato, K; Yamashita, T	1
Boustani, MA; Callahan, CM; Campbell, NL; Fowler, N; Gao, S; Hendrie, HC; Li, L; Perkins, AJ; Skaar, TC	1
Goebert, D; Guilloux, A; Higa, J; Lu, BY; Schultz, BR; Takeshita, J; Takeshita, S	1
Avila, A; Lawler, E	1
Bradley, J; Chan, P; Herrmann, N; Lanctôt, K; Mohammad, D	1
Ali, MR; Boutajangout, A; Mezei, M; Møller, SG; Sadoqi, M	1
Chang, CT; Chen, YH; Chiang, JH; Lai, CY; Lin, JG; Sun, MF; Wu, MY; Yen, HR	1
Godyń, J; Malawska, B; Panek, D; Pasieka, A; Wichur, T	1
Bellman, S	1
Kaushik, V; Mikobi, E; Raji, MA; Smith, ST	1
Abdel-Megied, AM; Aboul-Enein, HY; Hanafi, RS	1
Chang, SY; Dong, L; Feng, M; Guo, X; Hügel, H; Hyde, AJ; Lu, C; May, BH; Xue, CC; Zhang, AL	1
Atri, A; Ballard, C; Boneva, N; Cummings, JL; Frölich, L; Molinuevo, JL; Raket, LL; Tariot, PN; Windfeld, K	1
Asghari, A; Mirparizi, E; Rajabi, M	1
Cho, AH; Kim, JS; Lim, EY; Yang, DW	1
Gkioka, M; Kazmierski, J; Messini-Zachou, C; Tsolaki, M	1
Baranowska-Bosiacka, I; Chlubek, D; Goschorska, M; Gutowska, I; Metryka, E; Piotrowska, K; Safranow, K; Tarnowski, M	1
Hang, L; Jia, R; Li, J; Liang, J; Wang, Y; Wu, R; Xu, Y; Zhang, H	1
Baranowska-Bosiacka, I; Chlubek, D; Goschorska, M; Gutowska, I; Metryka, E; Piotrowska, K; Safranow, K	1
Buckley, N; Le Couteur, DG; Litchfield, M; McLachlan, AJ; Narayan, SW; Pearson, SA; Zoega, H	1
Chan, TY; Chan, WC; Chiu, J; Kng, CPL; Kong, HL; Lam, LCW; Lau, KH; Law, CB; Lin, KL; Ma, SL; Poon, TK; Tam, CCW; Tang, JHY; Tang, NLS; Wat, KHY	1
Bernal-Cobo, R; Calvo-Torres, LF; Gaviria-Mendoza, A; Machado-Alba, JE; Trujillo-Quintero, PM	1
Coenen, A; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Leitz, P; Niehues, P	1
Jacob, L; Kosik, J; Kostev, K; Kurylo, P	1
Alcaro, S; Borges, F; Chavarria, D; Gaspar, A; Mesiti, F	1
Fleet, JL; Garg, AX; McArthur, E; Montero-Odasso, M; Patel, A; Weir, MA	1
Asadipour, A; Eskandari, K; Pourshojaei, Y	1
Ahmed, M; Aleya, L; Ashraf, GM; Barreto, GE; Begum, MM; Kabir, MT; Mathew, B; Rahman, MS; Thangapandiyan, S; Uddin, MS	1
Sharma, P; Shrivastava, SK; Tripathi, MK	1
Chakkamparambil, B; Friedman, L; Grossberg, GT; Haake, A; Nguyen, K	1
Honjo, Y; Ide, K; Takechi, H	1
Aksoz, BE; Aksoz, E	1
Alajmi, MF; Anwar, S; Hasan, GM; Hassan, MI; Hussain, A; Islam, A; Mohammad, T; Rehman, MT; Shamsi, A	1
Barthold, D; Drabo, EF; Ferido, P; Gray, SL; Joyce, G; Marcum, ZA; Zissimopoulos, J	1
Bülbül, EÖ; Karantas, ID; Mutlu, G; Okur, ME; Okur, NÜ; Siafaka, PI	1
Ali, N; Arora, M; Ghai, R; Grover, P; Kapoor, G; Nagarajan, K	1
Alsabbagh, MW; Huang, Y	1
Buerger, K; Diehl-Schmid, J; Förstl, H; Grimmer, T; Müller, C; Müller-Sarnowski, F; Ortner, M; Schneider, H; Schröder, C; Stange, M; Steimer, W	1
Amenta, F; Ben, DD; Buccioni, M; Lambertucci, C; Marucci, G; Volpini, R	1
Aldridge, GM; Anderson, SW; Narayanan, NS; Uc, EY; Zhang, Q	1
Chmielewska, K; Dzierzbicka, K; Inkielewicz-Stepniak, I; Kowalski, S; Przybyłowska, M	1
Han, E; Kalisch Ellett, L; Lee, HJ; Lee, J; Roughead, EE	1
Abdul-Rahim, AH; Battle, CE; Hewitt, J; Quinn, TJ; Shenkin, SD	1
Halminen, O; Hörhammer, I; Linna, M; Mehtälä, J; Mikkola, T; Vesikansa, A; Virta, LJ; Ylisaukko-Oja, T	1
Fitzgerald, PJ; Ghimire, A; Hale, PJ; Watson, BO	1
Durães, F; Ndongo, TM; Passos, MLC; Pinto, M; Resende, DISP; Saraiva, MLMFS; Sousa, E	1
Bu, K; Cheng, F; Morris, R; Umeukeje, G	1
Natarajan, R; Raji, V; Sivaraman, B; Velmurugan, BA	1
Hoe, HS; Jeong, HR; Kim, J; Lee, H; Lee, HJ; Lee, S; Park, JH; Park, SK; Seol, E	1
Aparasu, RR; Chatterjee, S; Chen, H; Johnson, ML; Masurkar, PP; Sherer, JT	2
Ai, Y; Cheng, Y; Fan, F; Liu, H; Liu, Q; Shi, X	1
Cui, Y; Ren, G; Shi, X; Xu, Z	1
Bawany, MH; Florentino, SA; Ma, HM	1
Mehranfar, F; Saeedi, M	1
Bak, SH; Byeon, GH; Byun, J; Choi, HS; Chun, IK; Heo, J; Hong, Y; Jang, JW; Jeong, CW; Kasani, PH; Kim, JA; Kim, JH; Kim, JK; Kim, KL; Kim, S; Kim, WJ; Kim, Y; Kwon, SO; Lee, DY; Lee, EJ; Lee, K; Lee, SA; Moon, KW; Nam, SJ; Park, JI; Park, SW; Park, YJ; Rhee, HY	1
Bos, JHJ; de Vos, S; Hak, E; Hutten, DR	1
Ashoor, HM; Clarke, M; Hemmelgarn, BR; Holroyd-Leduc, J; Mavridis, D; Rios, P; Seitidis, G; Stewart, L; Straus, SE; Tricco, AC; Tudur-Smith, C; Veroniki, AA	1
Larkin, HD	1
Hughes, C; Lim, WY; Loy, C; McGuinness, B; Parsons, C; Passmore, P; Ward, SA	1
Bai, P; Ban, Y; Hu, J; Mi, J; Sang, Z; Tan, Z; Tang, L; Wang, C; Wang, J; Wang, K; Wu, A; Xu, R; Zhang, J; Zhu, G	1
Majidazar, R; Naseri, A; Rezazadeh-Gavgani, E; Sadigh-Eteghad, S	1
Abdelhady, GT; Abu-El-Rub, E; Al-Soudi, HS; Alzu'bi, A; Khasawneh, RR	1
Bu, K; Cheng, F; Han, W; Morris, R; Patel, D; Umeukeje, G; Zhu, T	1
Ayaz, M; Islam, ZU; Nawaz, A; Naz, F; Sadiq, A; Ullah, F	1
Chan, AHY; Cheung, G; Cullum, S; Hikaka, JA; Ma'u, E; Rivera-Rodriguez, C; Ryan, B; To, E	1
Andersen, K; Grøntved, S; Lolk, A; Nielsen, RE; Valentin, JB	1
Abraham, R; Benade, V; Gagginapally, SR; Ganuga, N; Grandhi, VR; Jayarajan, P; Medapati, R; Mohammed, AR; Nirogi, R; Palacharla, VRC; Petlu, S; Ravella, SR; Srirangavaram, M; Subramanian, R; Thentu, JB	1
Pant, A; Vasundhara, M	1
Ando, A; Enomoto, H; Kose, E; Tate, N; Yamamoto, T; Yasuno, N	1
Yamada, M	1
Cox, GR; Haslam, R; Ure, A; Williams, K	1
Hu, C; Inderjeeth, CA; Li, S; Liu, L; Teguh, D; Wu, D; Xu, J; Yuan, J	1
Adelman, M; Louis, L	1
He, Y; Liu, W; Ma, Q; Mi, J; Sang, Z; Tan, Z; Teng, X; Wei, R; Yang, J; Zhou, Y	1
Boada, M; Carnero-Pardo, C; Fortea, J; García-Ribas, G; Martínez-Lage, P; Olazarán, J; Sánchez-Juan, P; Viñuela, F	1
Algharably, EEA; Bermpohl, F; Bittner, N; Brandl, EJ; Funk, CSM; Kreutz, R; Riemer, TG; Schmidt, A	1
Ahuja, M; Gabor, C; Karimi, A; Lee, J; Lewis, K; Patterson, C; Reppas-Rindlisbacher, C; Siddhpuria, S; Sood, E; Wong, E	1

Reviews

155 review(s) available for rivastigmine and donepezil

Article	Year
Multi-target-directed ligands to combat neurodegenerative diseases. Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid	2008
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018). Bioorganic & medicinal chemistry, 2019, 03-15, Volume: 27, Issue:6 Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents	2019
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy. Bioorganic & medicinal chemistry letters, 2020, 02-01, Volume: 30, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Cholinesterases; Humans; Ligands; Monoamine Oxidase; Neuroprotective Agents; Oxidative Stress; Pargyline; Propylamines	2020
New therapeutic approaches to Alzheimer's disease. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 14 Topics: Alzheimer Disease; Antioxidants; Carbamates; Cholinergic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Trichlorfon	1996
[Therapeutic agents for Alzheimer's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Jan-10, Volume: 87, Issue:1 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Humans; Indans; Monoamine Oxidase Inhibitors; Neuropeptides; Phenylcarbamates; Piperidines; Receptor, Muscarinic M1; Receptors, Muscarinic; Rivastigmine; Spiro Compounds; Tacrine	1998
New therapeutic approaches to cognitive impairment. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 11 Topics: Aged; Alzheimer Disease; Antioxidants; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Humans; Indans; Monoamine Oxidase Inhibitors; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Trichlorfon	1998
Treatment of Alzheimer's disease: an evaluation of the cholinergic approach. Acta neurologica Belgica, 1999, Volume: 99, Issue:2 Topics: Acetylcholine; Alzheimer Disease; Animals; Carbamates; Chemical and Drug Induced Liver Injury; Cholinergic Agents; Cholinergic Fibers; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Double-Blind Method; Drug Evaluation, Preclinical; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Nicotinic; Rivastigmine; Tacrine	1999
Cholinesterase inhibitors stabilize Alzheimer's disease. Annals of the New York Academy of Sciences, 2000, Volume: 920 Topics: Alzheimer Disease; Brain; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Trichlorfon	2000
Cholinesterase inhibitors for Alzheimer's disease. Drugs, 2001, Volume: 61, Issue:1 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Cost-Benefit Analysis; Donepezil; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2001
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health technology assessment (Winchester, England), 2001, Volume: 5, Issue:1 Topics: Alzheimer Disease; Carbamates; Cost-Benefit Analysis; Donepezil; Galantamine; Humans; Indans; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2001
Use of cholinesterase inhibitors for treatment of Alzheimer disease. Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:7 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2001
[Current strategies of pathogenetic therapy of Alzheimer's disease]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2001, Issue:7 Topics: Aged; Alzheimer Disease; Amino Acids; Aminoquinolines; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Estrogens; Ginkgo biloba; Humans; Indans; Memantine; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Neuronal Plasticity; Neuroprotective Agents; Neurotransmitter Agents; Nicergoline; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Piracetam; Pyrithioxin; Rivastigmine; Selegiline; Tacrine; Time Factors	2001
[Anticholinesterase agents in Alzheimer's disease]. Revue medicale de Bruxelles, 2001, Volume: 22, Issue:4 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carbamates; Cholinesterase Inhibitors; Diagnosis, Differential; Disease Progression; Donepezil; Drug Therapy, Combination; Estrogen Replacement Therapy; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Prognosis; Rivastigmine; Treatment Outcome	2001
[A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia]. Fortschritte der Medizin. Originalien, 2001, Nov-29, Volume: 119, Issue:3-4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Double-Blind Method; Female; Ginkgo biloba; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Phytotherapy; Piperidines; Plant Extracts; Randomized Controlled Trials as Topic; Rivastigmine; Trichlorfon	2001
[Perspectives for drug treatment in Alzheimer's disease]. Annales de medecine interne, 2001, Volume: 152, Issue:8 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2001
Guidelines for managing Alzheimer's disease: Part II. Treatment. American family physician, 2002, Jun-15, Volume: 65, Issue:12 Topics: Advance Directives; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Disease Progression; Donepezil; Humans; Indans; Lorazepam; Patient Education as Topic; Phenylcarbamates; Piperidines; Risperidone; Rivastigmine	2002
Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine. Current medical research and opinion, 2002, Volume: 18, Issue:3 Topics: Acetylcholine; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Disease Progression; Donepezil; Galantamine; Humans; Indans; Neuroprotective Agents; Phenylcarbamates; Physostigmine; Piperidines; Rivastigmine; Tacrine; Time Factors; Treatment Outcome	2002
Clinical use of cholinomimetic agents: a review. The Journal of head trauma rehabilitation, 2002, Volume: 17, Issue:4 Topics: Administration, Oral; Adult; Aged; Alzheimer Disease; Brain Injuries; Carbamates; Clinical Trials as Topic; Cytidine Diphosphate Choline; Donepezil; Female; Follow-Up Studies; Humans; Indans; Injections, Intravenous; Injury Severity Score; Male; Middle Aged; Parasympathomimetics; Phenylcarbamates; Physostigmine; Piperidines; Rivastigmine; Severity of Illness Index; Tacrine; Treatment Outcome	2002
Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. Clinical therapeutics, 2002, Volume: 24, Issue:6 Topics: Aged; Alzheimer Disease; Canada; Carbamates; Cholinesterase Inhibitors; Cost-Benefit Analysis; Donepezil; Humans; Indans; Middle Aged; Multicenter Studies as Topic; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2002
The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. International journal of clinical practice. Supplement, 2002, Issue:127 Topics: Behavioral Symptoms; Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2002
The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. International journal of clinical practice. Supplement, 2002, Issue:127 Topics: Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2002
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clinical pharmacokinetics, 2002, Volume: 41, Issue:10 Topics: Aging; Alzheimer Disease; Biological Availability; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Interactions; Half-Life; Humans; Indans; Intestinal Absorption; Liver; Phenylcarbamates; Piperidines; Protein Binding; Rivastigmine; Tacrine; Tissue Distribution	2002
Medical treatment of Alzheimer's disease: past, present, and future. Medicine and health, Rhode Island, 2002, Volume: 85, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Forecasting; Galantamine; Humans; Indans; Male; Phenylcarbamates; Piperidines; Prognosis; Rivastigmine; Severity of Illness Index; Tacrine; Treatment Outcome	2002
Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease. Mini reviews in medicinal chemistry, 2001, Volume: 1, Issue:3 Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Binding Sites; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Design; Humans; Indans; Molecular Conformation; Molecular Structure; Phenylcarbamates; Piperidines; Rivastigmine; Structure-Activity Relationship; Tacrine	2001
Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review. International journal of technology assessment in health care, 2002,Summer, Volume: 18, Issue:3 Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Cost of Illness; Cost-Benefit Analysis; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Quality of Life; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2002
[Anti-dementia drugs for Alzheimer disease in present and future]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2002, Volume: 120, Issue:1 Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Design; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; tau Proteins	2002
A clinical overview of cholinesterase inhibitors in Alzheimer's disease. International psychogeriatrics, 2002, Volume: 14 Suppl 1 Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dose-Response Relationship, Drug; Galantamine; Humans; Indans; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2002
Current treatments for Alzheimer's disease: cholinesterase inhibitors. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 9 Topics: Alzheimer Disease; Behavioral Symptoms; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Multicenter Studies as Topic; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2003
Dementia. Clinical evidence, 2003, Issue:9 Topics: Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Carbamates; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Nootropic Agents; Phenylcarbamates; Phosphatidylcholines; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine; Vitamin E	2003
[Current therapy of patients with dementia]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dementia; Dementia, Vascular; Donepezil; Dopamine Agents; Female; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Meta-Analysis as Topic; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Placebos; Plant Preparations; Prospective Studies; Rivastigmine; Tacrine; Time Factors	2003
[Subcortical vascular encephalopathy]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:9 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amantadine; Brain; Carbamates; Clinical Trials as Topic; Dementia, Vascular; Diagnosis, Differential; Donepezil; Dopamine Agents; Gait; Humans; Indans; Magnetic Resonance Imaging; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Pilot Projects; Piperidines; Placebos; Prognosis; Risk Factors; Rivastigmine; Time Factors; Tomography, X-Ray Computed; Walking	2003
[Mechanisms of action of Alzheimer medications]. Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:20 Topics: Alzheimer Disease; Animals; Carbamates; Cholinesterase Inhibitors; Cognition; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Rivastigmine	2003
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. Current medical research and opinion, 2003, Volume: 19, Issue:8 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Female; Humans; Indans; Male; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Rivastigmine; Treatment Failure; Treatment Outcome	2003
Acetylcholinesterase inhibition in Alzheimer's Disease. Current pharmaceutical design, 2004, Volume: 10, Issue:3 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2004
Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. International journal of geriatric psychiatry, 2004, Volume: 19, Issue:6 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Down Syndrome; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2004
Evidence-based pharmacotherapy of Alzheimer's disease. The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:3 Topics: Aged; Alzheimer Disease; Carbamates; Cholinergic Agents; Cholinesterase Inhibitors; Cost-Benefit Analysis; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Research Design; Rivastigmine	2004
Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration. Dementia and geriatric cognitive disorders, 2004, Volume: 18, Issue:2 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Multicenter Studies as Topic; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Plant Extracts; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2004
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert opinion on drug safety, 2004, Volume: 3, Issue:5 Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome	2004
Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Journal of the neurological sciences, 2004, Nov-15, Volume: 226, Issue:1-2 Topics: Aged; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Parasympathetic Nervous System; Phenylcarbamates; Piperidines; Rivastigmine	2004
The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. The Journal of neuropsychiatry and clinical neurosciences, 2004,Fall, Volume: 16, Issue:4 Topics: Aged; Basal Ganglia Diseases; Behavior; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Cognition Disorders; Donepezil; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Tacrine	2004
Dementia. Clinical evidence, 2004, Issue:11 Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E	2004
Cholinesterase inhibitors in the treatment of dementia. The Journal of the American Osteopathic Association, 2005, Volume: 105, Issue:3 Topics: Acetylcholine; Acetylcholinesterase; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cost of Illness; Dementia; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index	2005
Dementia. Clinical evidence, 2004, Issue:12 Topics: Alzheimer Disease; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine	2004
Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years. International journal of clinical practice, 2005, Volume: 59, Issue:7 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Galantamine; Humans; Indans; Long-Term Care; Phenylcarbamates; Piperidines; Rivastigmine	2005
Pharmacologic treatment options in Alzheimer's disease: optimizing disease management. Journal of the American Academy of Nurse Practitioners, 2005, Volume: Suppl Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Disease Management; Donepezil; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Galantamine; Glutamic Acid; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Severity of Illness Index; Tacrine; Treatment Outcome	2005
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ (Clinical research ed.), 2005, Aug-06, Volume: 331, Issue:7512 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2005
Drug therapy of dementia in elderly patients. A review. Nordic journal of psychiatry, 2005, Volume: 59, Issue:2 Topics: Aged; Alzheimer Disease; Dementia; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2005
Clinical trials in mild cognitive impairment: lessons for the future. Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:4 Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Lactones; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Severity of Illness Index; Sulfones; Vitamin E	2006
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. International journal of geriatric psychiatry, 2006, Volume: 21, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quality of Life; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2006
Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy. Dementia and geriatric cognitive disorders, 2006, Volume: 21, Issue:2 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Circadian Rhythm; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Sleep; Sleep, REM	2006
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health technology assessment (Winchester, England), 2006, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cost-Benefit Analysis; Donepezil; Dopamine Agents; Evidence-Based Medicine; Female; Galantamine; Humans; Indans; Male; Memantine; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome; United Kingdom	2006
Cholinesterase inhibitors for Alzheimer's disease. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2006
Dementia. Clinical evidence, 2005, Issue:14 Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine	2005
Current and emerging pharmacological treatment options for dementia. Behavioural neurology, 2006, Volume: 17, Issue:1 Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2006
Alzheimer's disease. Lancet (London, England), 2006, Jul-29, Volume: 368, Issue:9533 Topics: Aged; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Male; Molecular Biology; Phenylcarbamates; Piperidines; Plaque, Amyloid; Positron-Emission Tomography; Randomized Controlled Trials as Topic; Rivastigmine; tau Proteins	2006
[Pharmacotherapy for Alzheimer's disease]. Tijdschrift voor psychiatrie, 2006, Volume: 48, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2006
[Medical treatment of Alzheimer's disease]. Ugeskrift for laeger, 2006, Oct-02, Volume: 168, Issue:40 Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Dementia, Vascular; Disease Progression; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Memantine; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2006
Use of antidementia agents in vascular dementia: beyond Alzheimer disease. Mayo Clinic proceedings, 2006, Volume: 81, Issue:10 Topics: Cholinesterase Inhibitors; Dementia, Vascular; Diagnosis, Differential; Donepezil; Dopamine Agents; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Stroke	2006
Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy. Journal of psychiatry & neuroscience : JPN, 2006, Volume: 31, Issue:6 Topics: Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Schizophrenic Psychology; Treatment Outcome	2006
The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease. Journal of the American Medical Directors Association, 2007, Volume: 8, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Evidence-Based Medicine; Geriatric Assessment; Humans; Indans; Mental Disorders; Nootropic Agents; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Rivastigmine; Tacrine	2007
Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. International psychogeriatrics, 2007, Volume: 19, Issue:3 Topics: Aged; Alzheimer Disease; Cross-Cultural Comparison; Donepezil; Ethnicity; Galantamine; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Thiazoles; White People	2007
[Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies]. Deutsche medizinische Wochenschrift (1946), 2007, Jun-01, Volume: 132, Issue:22 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Publication Bias; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index; Treatment Outcome	2007
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. The Lancet. Neurology, 2007, Volume: 6, Issue:9 Topics: Cholinesterase Inhibitors; Databases, Bibliographic; Dementia, Vascular; Donepezil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Odds Ratio; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors; Treatment Outcome	2007
[Acetylcholinesterase inhibitors for dementia--an update]. MMW Fortschritte der Medizin, 2007, May-21, Volume: 149 Suppl 2 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors	2007
Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis. PharmacoEconomics, 2007, Volume: 25, Issue:9 Topics: Alzheimer Disease; Cost-Benefit Analysis; Disease Progression; Donepezil; Galantamine; Humans; Indans; Memantine; Models, Economic; Phenylcarbamates; Piperidines; Rivastigmine	2007
[Are anti-dementia drugs worthwhile?]. MMW Fortschritte der Medizin, 2007, Sep-13, Volume: 149 Suppl 3 Topics: Activities of Daily Living; Alzheimer Disease; Antiparkinson Agents; Cholinesterase Inhibitors; Cost-Benefit Analysis; Donepezil; Dopamine Agents; Drug Therapy, Combination; Economics, Medical; Excitatory Amino Acid Antagonists; Galantamine; Germany; Health Policy; Humans; Indans; Memantine; Meta-Analysis as Topic; Neuroprotective Agents; Nootropic Agents; Parasympathomimetics; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors	2007
[Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview]. Der Nervenarzt, 2008, Volume: 79, Issue:1 Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Physostigmine; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2008
Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Current medicinal chemistry, 2007, Volume: 14, Issue:25 Topics: Alkaloids; Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Indole Alkaloids; Isoquinolines; Phenylcarbamates; Physostigmine; Piperidines; Propidium; Rivastigmine; Steroids; Tacrine	2007
Diagnosis and management of vascular cognitive impairment. Current atherosclerosis reports, 2007, Volume: 9, Issue:4 Topics: Central Nervous System Agents; Clinical Trials as Topic; Cognition Disorders; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine	2007
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Jan-31, Volume: 128, Issue:3 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome	2008
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
Pharmacologic management of Alzheimer disease. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2008, Volume: 40, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Memantine; N-Methylaspartate; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2008
[Treatment of Alzheimer's disease: status quo and future considerations]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2008, Volume: 131, Issue:5 Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Behavioral Symptoms; Choline; Cholinesterase Inhibitors; Cognition; Donepezil; Drug Design; Galantamine; Glutamic Acid; Humans; Indans; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Risk Factors; Rivastigmine	2008
Diagnosis and treatment of dementia with Lewy bodies. JAAPA : official journal of the American Academy of Physician Assistants, 2008, Volume: 21, Issue:5 Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Phenylcarbamates; Piperidines; Prognosis; Rivastigmine; Tacrine	2008
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clinical interventions in aging, 2008, Volume: 3, Issue:2 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2008
Pharmacological treatment in moderate-to-severe Alzheimer's disease. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:15 Topics: Alzheimer Disease; Donepezil; Double-Blind Method; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Placebos; Randomized Controlled Trials as Topic; Rivastigmine; Selegiline; Severity of Illness Index; Vitamin E	2008
Discontinuing Alzheimer's disease drug therapy: why, when, and how. Director (Cincinnati, Ohio), 2008,Winter, Volume: 16, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Approval; Drug Monitoring; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nursing Homes; Patient Selection; Phenylcarbamates; Piperidines; Prevalence; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Severity of Illness Index; Treatment Failure; United States; Withholding Treatment	2008
Treatment of Alzheimer's disease in the long-term-care setting. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, May-15, Volume: 66, Issue:10 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Dopamine Agents; Galantamine; Humans; Indans; Long-Term Care; Memantine; Phenylcarbamates; Piperidines; Rivastigmine	2009
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. International psychogeriatrics, 2009, Volume: 21, Issue:5 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Mental Disorders; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2009
Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta pharmacologica Sinica, 2009, Volume: 30, Issue:7 Topics: Acetylcholine; Alkaloids; Animals; Anti-Inflammatory Agents; Cholinergic Agents; Cholinesterase Inhibitors; Dementia, Vascular; Disease Models, Animal; Donepezil; Galantamine; Humans; Indans; Inflammation; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, Cholinergic; Rivastigmine; Sesquiterpenes; Signal Transduction	2009
Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence. Dementia and geriatric cognitive disorders, 2009, Volume: 28, Issue:5 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2009
Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch. CNS neuroscience & therapeutics, 2010,Spring, Volume: 16, Issue:1 Topics: Administration, Cutaneous; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Databases, Factual; Donepezil; Female; Humans; Indans; Male; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Retrospective Studies; Rivastigmine	2010
Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials. International journal of clinical practice, 2010, Volume: 64, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Aged; Alzheimer Disease; Blood Pressure; Capsules; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Phenylcarbamates; Piperidines; Pulse; Randomized Controlled Trials as Topic; Respiration; Rivastigmine	2010
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacological research, 2010, Volume: 61, Issue:6 Topics: Cholinesterase Inhibitors; Cognition; Donepezil; Emotions; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Motivation; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2010
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature. BMC psychiatry, 2010, Sep-07, Volume: 10 Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Hallucinations; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Modern care for patients with Alzheimer disease: rationale for early intervention. The Journal of the American Osteopathic Association, 2010, Volume: 110, Issue:9 Suppl 8 Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Cognition; Donepezil; Excitatory Amino Acid Antagonists; Humans; Immunosuppressive Agents; Indans; Memantine; Neuroprotective Agents; Phenylcarbamates; Piperidines; Psychological Tests; Rivastigmine; Severity of Illness Index; Tacrolimus	2010
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Deutsches Arzteblatt international, 2010, Volume: 107, Issue:39 Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2010
Switching cholinesterase inhibitors in older adults with dementia. International psychogeriatrics, 2011, Volume: 23, Issue:3 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Rivastigmine; Treatment Outcome	2011
[Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales]. Psychiatrische Praxis, 2011, Volume: 38, Issue:5 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Caregivers; Donepezil; Galantamine; Geriatric Assessment; Ginkgo biloba; Humans; Indans; Institutionalization; Memantine; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Plant Extracts; Randomized Controlled Trials as Topic; Rivastigmine	2011
[Cholinesterase inhibitors for treating dementia. Review]. Vertex (Buenos Aires, Argentina), 2010, Volume: 21 Suppl Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine	2010
Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. Expert opinion on investigational drugs, 2011, Volume: 20, Issue:9 Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cholinesterase Inhibitors; Cognition; Donepezil; Galantamine; Humans; Indans; Memantine; Neurons; Oxidative Stress; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Rivastigmine	2011
New drugs for Alzheimer's disease in Japan. Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:5 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Discovery; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Japan; Memantine; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2011
Pharmacologic treatment for memory disorder in multiple sclerosis. The Cochrane database of systematic reviews, 2011, Oct-05, Issue:10 Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2011
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. British journal of clinical pharmacology, 2012, Volume: 73, Issue:4 Topics: Alzheimer Disease; Clinical Trials as Topic; Donepezil; Drug Discovery; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Phenylcarbamates; Piperidines; Plaque, Amyloid; Rivastigmine; tau Proteins	2012
Effective pharmacological management of Alzheimer's disease. The American journal of managed care, 2011, Volume: 17 Suppl 13 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Disease Progression; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Time Factors; Treatment Outcome	2011
Acetylcholinesterase inhibitors for schizophrenia. The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1 Topics: Antipsychotic Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Psychotic Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Schizophrenia; Schizophrenic Psychology	2012
Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harbor perspectives in medicine, 2012, Volume: 2, Issue:3 Topics: Alkaloids; Alzheimer Disease; Amino Acids; Animals; Cholinesterase Inhibitors; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Donepezil; Drug Approval; Galantamine; Ginkgo biloba; Half-Life; History, 20th Century; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Psychotropic Drugs; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Sesquiterpenes; Vitamin B Complex; Vitamin E	2012
Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:4 Topics: Antidepressive Agents; Cholinesterase Inhibitors; Cognition Disorders; Depression; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine	2012
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. The Cochrane database of systematic reviews, 2012, Mar-14, Issue:3 Topics: Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2012
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health technology assessment (Winchester, England), 2012, Volume: 16, Issue:21 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cost-Benefit Analysis; Donepezil; Dopamine Agents; Female; Galantamine; Humans; Indans; Male; Memantine; Middle Aged; Models, Economic; Phenylcarbamates; Piperidines; Rivastigmine; Technology Assessment, Biomedical	2012
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease. Clinical pharmacokinetics, 2013, Volume: 52, Issue:4 Topics: Aging; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Pharmacogenetics; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2013
A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. Journal of Alzheimer's disease : JAD, 2013, Volume: 35, Issue:2 Topics: Aged; Alzheimer Disease; Behavior; Cholinesterase Inhibitors; Cognition; Data Interpretation, Statistical; Disability Evaluation; Disease Progression; Donepezil; Female; Galantamine; Humans; Indans; Male; Memantine; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2013
Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors. Clinical interventions in aging, 2013, Volume: 8 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Communication Disorders; Donepezil; Galantamine; Humans; Indans; Outcome Assessment, Health Care; Phenylcarbamates; Piperidines; Rivastigmine	2013
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Nov-05, Volume: 185, Issue:16 Topics: Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2013
Drugs for cognitive loss and dementia. Treatment guidelines from the Medical Letter, 2013, Volume: 11, Issue:134 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2013
[Development of therapies for Alzheimer's disease based on cholinergic hypothesis-status quo and future directions]. Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11 Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinergic Neurons; Cholinesterase Inhibitors; Donepezil; Drug Discovery; Galantamine; Humans; Indans; Molecular Targeted Therapy; Neuroprostanes; Phenylcarbamates; Piperidines; Rivastigmine	2013
Pharmacological treatment for memory disorder in multiple sclerosis. The Cochrane database of systematic reviews, 2013, Dec-17, Issue:12 Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2013
Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease. Biomedical chromatography : BMC, 2014, Volume: 28, Issue:11 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Donepezil; Galantamine; Humans; Indans; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Tandem Mass Spectrometry	2014
Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Journal of Alzheimer's disease : JAD, 2014, Volume: 41, Issue:2 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2014
[Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cholinesterase Inhibitors; Cognitive Dysfunction; Dementia; Disease Progression; Donepezil; Education, Medical, Continuing; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Peptide Fragments; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Reference Standards; Rivastigmine; tau Proteins; Tomography, Emission-Computed, Single-Photon	2014
[Memory-enhancing drugs]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2014, Volume: 143, Issue:5 Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element-Binding Protein; Donepezil; Drug Discovery; Extracellular Signal-Regulated MAP Kinases; Galantamine; Hippocampus; Humans; Indans; Long-Term Potentiation; Memantine; Memory; Memory Disorders; Molecular Targeted Therapy; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Synaptic Transmission	2014
[Progress of dementia medicine: Special reference to Alzheimer's disease]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 2014, Volume: 89, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cholinesterase Inhibitors; Donepezil; Drug Discovery; Galantamine; Humans; Indans; Magnetic Resonance Imaging; Memantine; Neurofibrillary Tangles; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Tomography, Emission-Computed, Single-Photon	2014
Understanding the beneficial and detrimental effects of donepezil and rivastigmine to improve their therapeutic value. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:4 Topics: Acetylcholine; Acetylcholinesterase; Amyloid beta-Peptides; Apolipoproteins E; Butyrylcholinesterase; Cholinesterase Inhibitors; Dementia; Donepezil; Humans; Indans; Microglia; Phenylcarbamates; Piperidines; Rivastigmine	2015
Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials? Clinical therapeutics, 2015, Volume: 37, Issue:8 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials, Phase III as Topic; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Piperidines; Rivastigmine; Treatment Outcome	2015
Cognitive impairment in Parkinson's disease. Psychiatria Danubina, 2015, Volume: 27, Issue:4 Topics: Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Humans; Memantine; Muscle Rigidity; Parkinson Disease; Risk Factors; Rivastigmine	2015
Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia. Current neuropharmacology, 2016, Volume: 14, Issue:4 Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Cholinesterase Inhibitors; Cognitive Behavioral Therapy; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Exercise Therapy; Galantamine; Humans; Indans; Memantine; Parkinson Disease; Piperidines; Rivastigmine; Sleep Wake Disorders; Treatment Outcome	2016
The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis. International journal of geriatric psychiatry, 2016, Volume: 31, Issue:8 Topics: Aged; Alzheimer Disease; Bayes Theorem; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Network Meta-Analysis; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2016
Promising Therapies for Alzheimer's Disease. Current pharmaceutical design, 2016, Volume: 22, Issue:14 Topics: Allosteric Regulation; Alzheimer Disease; Animals; Donepezil; Humans; Indans; Ligands; Neuroprotective Agents; Piperidines; Receptors, Cholinergic; Rivastigmine	2016
Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis. European neurology, 2016, Volume: 75, Issue:3-4 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Neuropsychological Tests; Piperidines; Rivastigmine	2016
Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics. Future medicinal chemistry, 2016, Volume: 8, Issue:6 Topics: Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Donepezil; Drug Discovery; Galantamine; Humans; Indans; Molecular Targeted Therapy; Piperidines; Rivastigmine; Structure-Activity Relationship	2016
Psychopharmacological Studies in Mice. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2016, Volume: 136, Issue:5 Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dopamine; Drug Discovery; Environment; Female; Galantamine; Indans; Male; Mental Disorders; Mice; Molecular Targeted Therapy; Motivation; Piperidines; Psychopharmacology; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1D; Receptors, Dopamine D2; Research; Rivastigmine	2016
Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:13 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Humans; Indans; Memantine; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Transdermal Patch	2016
Alzheimer Disease: Monotherapy vs. Combination Therapy. American family physician, 2017, Apr-01, Volume: 95, Issue:7 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Dopamine Agents; Drug Therapy, Combination; Galantamine; Humans; Indans; Memantine; Piperidines; Rivastigmine	2017
Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation. Expert opinion on drug safety, 2017, Volume: 16, Issue:9 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Drug Interactions; Galantamine; Humans; Indans; Piperidines; Rivastigmine; Severity of Illness Index	2017
Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors. Future medicinal chemistry, 2017, Volume: 9, Issue:15 Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Humans; Indans; Inhibitory Concentration 50; Piperidines; Rivastigmine; Tacrine	2017
Pharmacological treatment for memory disorder in multiple sclerosis. International journal of evidence-based healthcare, 2017, Volume: 15, Issue:4 Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2017
Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer's Disease. American journal of Alzheimer's disease and other dementias, 2018, Volume: 33, Issue:2 Topics: Alzheimer Disease; Cardiovascular Diseases; Cholinesterase Inhibitors; Comorbidity; Donepezil; Galantamine; Polypharmacy; Rivastigmine	2018
Comparisons between traditional medicines and pharmacotherapies for Alzheimer disease: A systematic review and meta-analysis of cognitive outcomes. International journal of geriatric psychiatry, 2018, Volume: 33, Issue:3 Topics: Alzheimer Disease; Asia, Eastern; Cholinesterase Inhibitors; Cognition; Donepezil; Galantamine; Humans; Indans; Medicine, Traditional; Memantine; Nootropic Agents; Piperidines; Plant Extracts; Rivastigmine	2018
Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review. Clinical interventions in aging, 2018, Volume: 13 Topics: Alzheimer Disease; Antiparkinson Agents; Bayes Theorem; Cholinesterase Inhibitors; Cognition; Donepezil; Galantamine; Humans; Memantine; Neuroprotective Agents; Nootropic Agents; Rivastigmine	2018
The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease. European journal of medicinal chemistry, 2019, Nov-01, Volume: 181 Topics: Alzheimer Disease; Animals; Chemistry Techniques, Synthetic; Donepezil; Dopamine Agents; Drug Design; Drug Discovery; Humans; Indans; Memantine; Molecular Targeted Therapy; Neuroprotective Agents; Nootropic Agents; Rivastigmine; Tacrine	2019
Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents. Mini reviews in medicinal chemistry, 2019, Volume: 19, Issue:19 Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Drug Design; Humans; Rivastigmine; Tacrine	2019
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning. Current pharmaceutical design, 2019, Volume: 25, Issue:33 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Repositioning; Galantamine; Humans; Rivastigmine; Tacrine	2019
An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease. Expert opinion on drug safety, 2020, Volume: 19, Issue:2 Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Rivastigmine	2020
Vital Role of Monoamine Oxidases and Cholinesterases in Central Nervous System Drug Research: A Sharp Dissection of the Pathophysiology. Combinatorial chemistry & high throughput screening, 2020, Volume: 23, Issue:9 Topics: Central Nervous System Agents; Central Nervous System Diseases; Cholinesterases; Combined Modality Therapy; Donepezil; Drug Design; Enzyme Inhibitors; Galantamine; Humans; Monoamine Oxidase; Rivastigmine; Structure-Activity Relationship; Tacrine	2020
Transdermal Drug Delivery Systems and their Potential in Alzheimer's Disease Management. CNS & neurological disorders drug targets, 2020, Volume: 19, Issue:5 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Delivery Systems; Humans; Memantine; Rivastigmine	2020
Current Strategies and Novel Drug Approaches for Alzheimer Disease. CNS & neurological disorders drug targets, 2020, Volume: 19, Issue:9 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Mice; Phytotherapy; Plant Preparations; Rats; Rivastigmine	2020
Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review. Pharmacology research & perspectives, 2020, Volume: 8, Issue:4 Topics: Alzheimer Disease; Animals; Arrhythmias, Cardiac; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Rivastigmine	2020
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease. Neuropharmacology, 2021, 06-01, Volume: 190 Topics: Alzheimer Disease; Antioxidants; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Galantamine; Humans; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2021
Approach to Cognitive Impairment in Parkinson's Disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020, Volume: 17, Issue:4 Topics: Arousal; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Executive Function; Humans; Memory, Episodic; Parkinson Disease; Quality of Life; Randomized Controlled Trials as Topic; Rivastigmine; Transcutaneous Electric Nerve Stimulation	2020
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. The Cochrane database of systematic reviews, 2021, 02-22, Volume: 2 Topics: Activities of Daily Living; Bias; Cholinesterase Inhibitors; Cognition; Dementia, Vascular; Donepezil; Galantamine; Humans; Network Meta-Analysis; Nootropic Agents; Physical Functional Performance; Placebos; Randomized Controlled Trials as Topic; Rivastigmine	2021
Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease. CNS & neurological disorders drug targets, 2022, Volume: 21, Issue:5 Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Rivastigmine	2022
The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review. Journal of Alzheimer's disease : JAD, 2022, Volume: 85, Issue:3 Topics: Activities of Daily Living; Alzheimer Disease; Amino Acids; Cholinesterase Inhibitors; Cognition; Donepezil; Galantamine; Ginkgo biloba; Humans; Nootropic Agents; Patient Safety; Plant Extracts; Rivastigmine	2022
Comparative Efficacy and Acceptability of Cholinesterase Inhibitors and Memantine Based on Dosage in Patients with Vascular Cognitive Impairment: A Network Meta-analysis. Current Alzheimer research, 2022, Volume: 19, Issue:2 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Galantamine; Humans; Indans; Memantine; Network Meta-Analysis; Nootropic Agents; Randomized Controlled Trials as Topic; Rivastigmine	2022
Acetylcholinesterase inhibitors to enhance recovery from traumatic brain injury: a comprehensive review and case series. Brain injury, 2022, 03-21, Volume: 36, Issue:4 Topics: Acetylcholinesterase; Adult; Brain Injuries, Traumatic; Child; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Piperidines; Rivastigmine	2022
Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease. Recent patents on biotechnology, 2022, Volume: 16, Issue:2 Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal, Humanized; Donepezil; Indans; Memantine; Patents as Topic; Piperidines; Rivastigmine	2022
Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis. BMJ open, 2022, 04-26, Volume: 12, Issue:4 Topics: Adult; Alzheimer Disease; Donepezil; Galantamine; Humans; Memantine; Network Meta-Analysis; Nootropic Agents; Rivastigmine	2022
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia. The Cochrane database of systematic reviews, 2021, 02-03, Volume: 2 Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Humans; Memantine; Parkinson Disease; Quality of Life; Rivastigmine	2021
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews. European journal of clinical pharmacology, 2022, Volume: 78, Issue:10 Topics: Alzheimer Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Glycogen Synthase Kinase 3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Indans; Lithium; Melatonin; Memantine; Neurodegenerative Diseases; Rivastigmine; Systematic Reviews as Topic	2022
Endophytic fungi: a potential source for drugs against central nervous system disorders. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023, Volume: 54, Issue:3 Topics: Central Nervous System Diseases; Donepezil; Endophytes; Fungi; Humans; Plants, Medicinal; Rivastigmine	2023
[Anti-Dementia Drugs (Anti-Alzheimer's Disease Drugs)]. Brain and nerve = Shinkei kenkyu no shinpo, 2023, Volume: 75, Issue:5 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Memantine; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2023
Acetylcholinesterase inhibitors for autistic spectrum disorders. The Cochrane database of systematic reviews, 2023, 06-01, Volume: 6 Topics: Acetylcholine; Adolescent; Autism Spectrum Disorder; Child; Child, Preschool; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Risperidone; Rivastigmine	2023
A Novel Formulation: Donepezil Patch. The Senior care pharmacist, 2023, Jul-01, Volume: 38, Issue:7 Topics: Acetylcholinesterase; Donepezil; Drug-Related Side Effects and Adverse Reactions; Humans; Rivastigmine; United States; United States Food and Drug Administration	2023
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis. Drugs & aging, 2023, Volume: 40, Issue:11 Topics: Acetylcholinesterase; Alzheimer Disease; Anorexia; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Sleep Initiation and Maintenance Disorders	2023
Cholinesterase inhibitors and falls, syncope and injuries in patients with cognitive impairment: a systematic review and meta-analysis. Age and ageing, 2023, 11-02, Volume: 52, Issue:11 Topics: Accidental Falls; Accidental Injuries; Cholinesterase Inhibitors; Cognitive Dysfunction; Donepezil; Fractures, Bone; Galantamine; Humans; Rivastigmine; Syncope	2023

Trials

33 trial(s) available for rivastigmine and donepezil

Article	Year
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil. Current medical research and opinion, 2002, Volume: 18, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Prospective Studies; Rivastigmine; Severity of Illness Index; Treatment Failure; Treatment Outcome	2002
Correlates of dropout, efficacy, and adverse events in treatment with acetylcholinesterase inhibitors in Korean patients with Alzheimer's disease. International psychogeriatrics, 2002, Volume: 14, Issue:2 Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Middle Aged; Patient Dropouts; Phenylcarbamates; Piperidines; Prospective Studies; Rivastigmine	2002
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:6 Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Female; Frontal Lobe; Humans; Indans; Magnetic Resonance Imaging; Male; Parietal Lobe; Phenylcarbamates; Piperidines; Reproducibility of Results; Rivastigmine; Temporal Lobe; Tomography, Emission-Computed	2002
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Donepezil; Enzyme-Linked Immunosorbent Assay; Galantamine; Humans; Indans; Peptide Fragments; Phenylcarbamates; Phosphorylation; Piperidines; Rivastigmine; tau Proteins	2002
The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:6 Topics: Acetylcholine; Aged; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Electroencephalography; Event-Related Potentials, P300; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Prospective Studies; Reaction Time; Rivastigmine; Tacrine; Treatment Outcome	2003
Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease. Neuroscience letters, 2003, Jun-12, Volume: 343, Issue:3 Topics: Aged; Alzheimer Disease; Apolipoproteins E; Carbamates; Cholesterol; Cholinesterase Inhibitors; Disease Progression; Donepezil; Female; Genotype; Humans; Indans; Male; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2003
Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. Current medical research and opinion, 2003, Volume: 19, Issue:4 Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Male; Nootropic Agents; Phenylcarbamates; Pilot Projects; Piperidines; Rivastigmine	2003
Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry, 2003, Volume: 36, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Electroencephalography; Female; Humans; Indans; Male; Memory; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Theta Rhythm; Time Factors; Treatment Outcome	2003
Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study. Archives of gerontology and geriatrics. Supplement, 2004, Issue:9 Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Female; Galantamine; Humans; Indans; Male; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Severity of Illness Index	2004
An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting. Current medical research and opinion, 2004, Volume: 20, Issue:11 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Mental Status Schedule; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2004
Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1 Topics: Adolescent; Adult; Aged; Brain Damage, Chronic; Brain Injuries; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Performance; Rivastigmine; Treatment Outcome	2005
Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology, 2004, Dec-28, Volume: 63, Issue:12 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Donepezil; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Patient Satisfaction; Patients; Phenylcarbamates; Physical Therapy Modalities; Piperidines; Psychomotor Disorders; Rivastigmine; Single-Blind Method; Treatment Outcome	2004
Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period. Dementia and geriatric cognitive disorders, 2005, Volume: 19, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Administration Schedule; Female; Galantamine; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Piperidines; Prospective Studies; Retrospective Studies; Rivastigmine; Severity of Illness Index; Time Factors	2005
A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease. European journal of clinical pharmacology, 2005, Volume: 61, Issue:5-6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Donepezil; Female; Follow-Up Studies; Galantamine; Humans; Indans; Italy; Male; Middle Aged; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome	2005
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period. Current medical research and opinion, 2005, Volume: 21, Issue:8 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Double-Blind Method; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome	2005
Treatment persistency with rivastigmine and donepezil in a large state medicaid program. Journal of the American Geriatrics Society, 2005, Volume: 53, Issue:7 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Patient Compliance; Phenylcarbamates; Piperidines; Research Design; Rivastigmine	2005
Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings. Journal of geriatric psychiatry and neurology, 2006, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Memory Disorders; Mental Recall; Mental Status Schedule; Neuropsychological Tests; Phenylcarbamates; Piperidines; Retention, Psychology; Rivastigmine; Verbal Learning	2006
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Current medical research and opinion, 2006, Volume: 22, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Donepezil; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Severity of Illness Index; Treatment Outcome	2006
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia. Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:11 Topics: Aged; Antiparkinson Agents; Brain; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Humans; Image Processing, Computer-Assisted; Indans; Male; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine; Tomography, Emission-Computed, Single-Photon	2006
Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs & aging, 2006, Volume: 23, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Polysomnography; Rivastigmine; Sleep Stages; Sleep Wake Disorders	2006
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease. Pharmacogenetics and genomics, 2006, Volume: 16, Issue:11 Topics: Aged; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Female; Genetic Variation; Genotype; Heterozygote; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Treatment Outcome	2006
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:4 Topics: Activities of Daily Living; Aged; Cholinesterase Inhibitors; Cognition Disorders; Combined Modality Therapy; Computer-Assisted Instruction; Donepezil; Female; Galantamine; Humans; Indans; Intelligence; Longitudinal Studies; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Nootropic Agents; Orientation; Phenylcarbamates; Piperidines; Problem Solving; Retrospective Studies; Rivastigmine; Software; Treatment Outcome	2007
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:2 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Analysis of Variance; Apolipoproteins E; Cholinesterase Inhibitors; Depression; Dietary Supplements; Donepezil; Double-Blind Method; Fatty Acids, Omega-3; Female; Galantamine; Genotype; Humans; Indans; Male; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Statistics, Nonparametric; Treatment Outcome	2008
A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:2 Topics: Aged; Alzheimer Disease; Analysis of Variance; Chi-Square Distribution; Cholinesterase Inhibitors; Dietary Supplements; Donepezil; Double-Blind Method; Female; Folic Acid; Folic Acid Deficiency; Galantamine; Homocysteine; Humans; Indans; Male; Mental Status Schedule; Phenylcarbamates; Piperidines; Placebos; Rivastigmine; Treatment Outcome; Vitamin B Complex; Vitamins	2008
Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Current Alzheimer research, 2009, Volume: 6, Issue:1 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Female; Galantamine; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2009
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis. Current medical research and opinion, 2010, Volume: 26, Issue:2 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Antiparkinson Agents; Cholinesterase Inhibitors; Donepezil; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indans; Male; Memantine; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Piperidines; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome	2010
Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population. Geriatrics & gerontology international, 2011, Volume: 11, Issue:3 Topics: Aged; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cognition; Delayed-Action Preparations; Donepezil; Female; Galantamine; Humans; Indans; Male; Patient Satisfaction; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2011
Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort. BMC neurology, 2012, Nov-05, Volume: 12 Topics: Activities of Daily Living; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Disabled Persons; Donepezil; Female; Galantamine; Humans; Indans; Linear Models; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2012
Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. Journal of Alzheimer's disease : JAD, 2014, Volume: 39, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Longitudinal Studies; Male; Memantine; Mental Disorders; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine	2014
Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study. Journal of Alzheimer's disease : JAD, 2014, Volume: 41, Issue:2 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Comorbidity; Donepezil; Female; Galantamine; Humans; Indans; Italy; Male; Memantine; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Retrospective Studies; Rivastigmine; Time Factors; Treatment Outcome	2014
Antidementia drug treatment in people screened positive for dementia in primary care. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:3 Topics: Aged; Aged, 80 and over; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Male; Memantine; Mental Status Schedule; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Primary Health Care; Rivastigmine	2015
Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial. Journal of the American Geriatrics Society, 2017, Volume: 65, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Ethnicity; Female; Galantamine; Humans; Indans; Indiana; Male; Medication Adherence; Piperidines; Rivastigmine	2017
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials. JAMA, 2018, 01-09, Volume: 319, Issue:2 Topics: Accidental Falls; Aged; Aged, 80 and over; Alzheimer Disease; Benzylamines; Cholinesterase Inhibitors; Cognition; Donepezil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Indans; Indoles; Male; Middle Aged; Piperidines; Rivastigmine; Serotonin Antagonists; Treatment Failure	2018

Other Studies

260 other study(ies) available for rivastigmine and donepezil

Article	Year
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines. Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17 Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship	2002
Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine. Journal of medicinal chemistry, 2005, Feb-24, Volume: 48, Issue:4 Topics: Acetylcholinesterase; Amyloid beta-Protein Precursor; Benzofurans; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Neurons; Oxepins; Structure-Activity Relationship	2005
Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors. Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17 Topics: Acetylcholinesterase; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Drug Design; Indans; Inhibitory Concentration 50; Ketones; Models, Molecular; Protein Binding; Rats; Structure-Activity Relationship	2005
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine. Journal of medicinal chemistry, 2006, Apr-06, Volume: 49, Issue:7 Topics: Acetophenones; Acetylcholinesterase; Animals; Benzofurans; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Heterocyclic Compounds, 3-Ring; Humans; Models, Molecular; Oxepins; Stereoisomerism; Structure-Activity Relationship; Torpedo	2006
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease. Journal of medicinal chemistry, 2007, Oct-04, Volume: 50, Issue:20 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Humans; Ligands; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Polyamines; Protein Binding; Quinones; Reactive Oxygen Species; Structure-Activity Relationship; Substrate Specificity	2007
Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives. European journal of medicinal chemistry, 2009, Volume: 44, Issue:1 Topics: Animals; Benzofurans; Cholinesterase Inhibitors; Drug Design; Indans; Memory; Mice; Pain; Structure-Activity Relationship	2009
Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors. Bioorganic & medicinal chemistry, 2009, Sep-15, Volume: 17, Issue:18 Topics: Acetylcholinesterase; Animals; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Computer Simulation; Flavonoids; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Phenylcarbamates; Protein Binding; Rats; Rivastigmine; Structure-Activity Relationship	2009
Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology. Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17 Topics: Acetylcholinesterase; Administration, Oral; Animals; Avoidance Learning; Caenorhabditis elegans; Carbamates; Catalytic Domain; Cholinesterase Inhibitors; Databases, Factual; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Mice; Models, Molecular; Nootropic Agents; Quantitative Structure-Activity Relationship; Scopolamine	2010
(+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase. Bioorganic & medicinal chemistry letters, 2011, May-01, Volume: 21, Issue:9 Topics: Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Computer Simulation; Inhibitory Concentration 50; Models, Biological; Models, Molecular; Molecular Structure; Pyrans	2011
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease. European journal of medicinal chemistry, 2011, Volume: 46, Issue:6 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Crystallography, X-Ray; Dose-Response Relationship, Drug; Erythrocytes; Models, Molecular; Molecular Structure; Quinolizidines; Stereoisomerism; Structure-Activity Relationship	2011
Species independence in brain tissue binding using brain homogenates. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity	2011
Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. Journal of medicinal chemistry, 2012, Nov-08, Volume: 55, Issue:21 Topics: Alkaloids; Amyloid beta-Protein Precursor; Animals; Brain; Cell Death; Cell Line; Chromatography, Affinity; Crystallography, X-Ray; Cyclin-Dependent Kinase 2; Dioxoles; Dyrk Kinases; Glutamic Acid; Humans; Imidazoles; In Vitro Techniques; Mice; Models, Molecular; Molecular Structure; Neuroprotective Agents; Porifera; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship	2012
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Bioorganic & medicinal chemistry, 2013, Jan-01, Volume: 21, Issue:1 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Coumarins; Horses; Humans	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease. European journal of medicinal chemistry, 2014, Feb-12, Volume: 73 Topics: Alzheimer Disease; Animals; Butyrylcholinesterase; Cannabinoid Receptor Agonists; Cholinesterase Inhibitors; Computational Biology; Drug Design; Horses; Humans; Indazoles; Ligands; Molecular Docking Simulation; Molecular Structure; Radioligand Assay; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2	2014
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease. Bioorganic & medicinal chemistry letters, 2014, Mar-15, Volume: 24, Issue:6 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cotinine; Humans; Neurons; Neuroprotective Agents; Nicotine; Peptide Fragments; Rats; Receptors, N-Methyl-D-Aspartate	2014
Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy. Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17 Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Curcumin; Dose-Response Relationship, Drug; Drug Design; Ligands; Molecular Docking Simulation; Molecular Structure; Phenylcarbamates; Rivastigmine; Structure-Activity Relationship	2014
Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2015, Apr-13, Volume: 94 Topics: Acetylcholinesterase; Alzheimer Disease; Amines; Amyloid beta-Peptides; Animals; Antioxidants; Apigenin; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Peroxide; Memory Disorders; Mice; Models, Molecular; Molecular Structure; PC12 Cells; Peptide Fragments; Rats; Scopolamine; Structure-Activity Relationship	2015
Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. European journal of medicinal chemistry, 2016, Jan-01, Volume: 107 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Binding Sites; Butyrylcholinesterase; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Computer Simulation; Coumarins; Drug Evaluation, Preclinical; Galantamine; Humans; Hydrogen Peroxide; Male; Mice, Inbred BALB C; Models, Molecular; Neuroprotective Agents; Neurotoxicity Syndromes	2016
Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease. Bioorganic & medicinal chemistry letters, 2016, Apr-15, Volume: 26, Issue:8 Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Benzylamines; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Humans; Molecular Structure; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Stilbenes; Structure-Activity Relationship	2016
Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies. European journal of medicinal chemistry, 2016, Aug-25, Volume: 119 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Humans; Kinetics; Molecular Docking Simulation; Peptide Fragments; Protein Aggregates; Protein Conformation; Pyrimidines	2016
Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment. Bioorganic & medicinal chemistry letters, 2016, 08-01, Volume: 26, Issue:15 Topics: 3-Hydroxyacyl CoA Dehydrogenases; Alzheimer Disease; Animals; Benzothiazoles; Cell Survival; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Urea	2016
Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening. Journal of medicinal chemistry, 2016, 08-25, Volume: 59, Issue:16 Topics: Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship	2016
Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation. European journal of medicinal chemistry, 2017, Jan-05, Volume: 125 Topics: Amines; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Binding Sites; Blood-Brain Barrier; Cholinesterases; Drug Delivery Systems; Drug Design; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Molecular Structure; Peptide Fragments; Phthalimides; Protein Aggregation, Pathological; Protein Binding; Saccharin	2017
Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease. European journal of medicinal chemistry, 2017, Jan-05, Volume: 125 Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cholinesterase Inhibitors; Coumaric Acids; Drug Discovery; Humans; In Vitro Techniques; Neuroprotective Agents; Rivastigmine; Structure-Activity Relationship	2017
Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation. Journal of medicinal chemistry, 2017, 07-13, Volume: 60, Issue:13 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid; Animals; Cholinesterase Inhibitors; Donepezil; Drug Design; Female; Humans; Indans; Mice; Molecular Docking Simulation; Piperidines; Prodrugs	2017
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease. European journal of medicinal chemistry, 2017, Oct-20, Volume: 139 Topics: Alzheimer Disease; Animals; Cinnamates; Dose-Response Relationship, Drug; Free Radical Scavengers; Glycogen Synthase Kinase 3 beta; Molecular Structure; Stereoisomerism; Structure-Activity Relationship	2017
Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease. European journal of medicinal chemistry, 2017, Dec-01, Volume: 141 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Biological Products; Butyrylcholinesterase; Cell Death; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Free Radical Scavengers; Glutamic Acid; Humans; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Rivastigmine; Structure-Activity Relationship	2017
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity. Journal of medicinal chemistry, 2018, 01-11, Volume: 61, Issue:1 Topics: Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Crystallography, X-Ray; Drug Design; Female; Humans; Kinetics; Male; Mice; Models, Molecular; Protein Binding; Protein Conformation; Rats; Safety; Thermodynamics; Tissue Distribution	2018
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. European journal of medicinal chemistry, 2018, Aug-05, Volume: 156 Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Caco-2 Cells; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Design; Humans; Ligands; Models, Molecular; Neuroprotective Agents; Piperidines	2018
Discovery of novel 2,5-dihydroxyterephthalamide derivatives as multifunctional agents for the treatment of Alzheimer's disease. Bioorganic & medicinal chemistry, 2018, 12-15, Volume: 26, Issue:23-24 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Butyrylcholinesterase; Chelating Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Peptide Fragments; Phthalimides; Protein Aggregates; Structure-Activity Relationship	2018
Indazolylketones as new multitarget cannabinoid drugs. European journal of medicinal chemistry, 2019, Mar-15, Volume: 166 Topics: Aspartic Acid Endopeptidases; Butyrylcholinesterase; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Drug Design; Humans; Indazoles; Ketones; Neurons; Receptor, Cannabinoid, CB2	2019
Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase. European journal of medicinal chemistry, 2019, Apr-01, Volume: 167 Topics: Acetylcholine; Alzheimer Disease; Animals; Cell Line; Cholinesterase Inhibitors; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Inflammation; Lipoxygenase Inhibitors; Mice; Molecular Docking Simulation; Neurons; PC12 Cells; Rats; Semicarbazides; Triazoles	2019
Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2019, Apr-01, Volume: 167 Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Cognitive Dysfunction; Drug Design; Humans; Mice; Piperidines; Protein Aggregation, Pathological; Structure-Activity Relationship	2019
Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2019, Apr-15, Volume: 168 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cell Line; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Inflammation; Isoflavones; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Structure; Neuroprotective Agents; Receptors, Histamine H3; Structure-Activity Relationship	2019
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease. ACS medicinal chemistry letters, 2019, Apr-11, Volume: 10, Issue:4 Topics:	2019
Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2019, Sep-15, Volume: 178 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Chalcones; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Eels; Female; Horses; Humans; Male; Maze Learning; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Peptide Fragments; Protein Aggregates; Rats; Structure-Activity Relationship	2019
Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2019, Oct-15, Volume: 180 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Chalcone; Cholinesterase Inhibitors; Drug Design; Eels; Horses; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Peptide Fragments; Protein Aggregates	2019
Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies. European journal of medicinal chemistry, 2019, Nov-01, Volume: 181 Topics: Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Humans; Molecular Docking Simulation; Naphthalenesulfonates; Pyrazoles; Structure-Activity Relationship	2019
Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease. European journal of medicinal chemistry, 2019, Dec-01, Volume: 183 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Female; Humans; Kinetics; Molecular Docking Simulation; Neuroprotective Agents; Oxadiazoles; Piperazines; Protein Aggregates; Pyridines; Rats, Wistar; Structure-Activity Relationship	2019
Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2020, Feb-01, Volume: 187 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apigenin; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Ligands; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Rats; Rivastigmine; Structure-Activity Relationship; Zebrafish	2020
The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2020, Apr-15, Volume: 192 Topics: Acetylcholinesterase; Aluminum Chloride; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Development; Humans; Ligands; Molecular Structure; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Structure-Activity Relationship; Zebrafish	2020
Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2020, May-15, Volume: 194 Topics: Alzheimer Disease; Amides; Amyloid beta-Peptides; Animals; Cell Line; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Mice; Mice, Inbred Strains; Microsomes, Liver; Molecular Structure; Peptide Fragments; Positron Emission Tomography Computed Tomography; Protein Aggregates; Rats; Structure-Activity Relationship; Zebrafish	2020
Simple analogues of natural product chelerythrine: Discovery of a novel anticholinesterase 2-phenylisoquinolin-2-ium scaffold with excellent potency against acetylcholinesterase. European journal of medicinal chemistry, 2020, Aug-15, Volume: 200 Topics: Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Discovery; Humans; Inhibitory Concentration 50; Isoquinolines; Molecular Docking Simulation; Structure-Activity Relationship	2020
The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors. European journal of medicinal chemistry, 2020, Sep-01, Volume: 201 Topics: Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Electrophorus; Enzyme Assays; Free Radical Scavengers; Hep G2 Cells; Horses; Humans; Kinetics; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Protein Binding; Pyrazoles; Structure-Activity Relationship	2020
Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile. European journal of medicinal chemistry, 2020, Oct-01, Volume: 203 Topics: Berberine; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Prolyl Oligopeptidases	2020
MicroRNA-Based Multitarget Approach for Alzheimer's Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b Biogenesis. Journal of medicinal chemistry, 2020, 09-10, Volume: 63, Issue:17 Topics: Acetylcholinesterase; Alzheimer Disease; Caco-2 Cells; Cholinesterase Inhibitors; Drug Discovery; Humans; MicroRNAs; Models, Molecular; Molecular Targeted Therapy; Nucleic Acid Conformation; Protein Conformation	2020
Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease. Bioorganic & medicinal chemistry, 2020, 11-15, Volume: 28, Issue:22 Topics: Acetylcholinesterase; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Male; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pyrrolidines; Rats; Rats, Wistar; Scopolamine; Structure-Activity Relationship	2020
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT European journal of medicinal chemistry, 2021, Jan-15, Volume: 210 Topics: Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Electrophorus; Humans; Locomotion; Male; Mice; Models, Molecular; Molecular Structure; Prodrugs; Receptors, Serotonin; Structure-Activity Relationship	2021
2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 2021, Feb-05, Volume: 211 Topics: Alzheimer Disease; Drug Design; Humans; Naphthoquinones; Structure-Activity Relationship	2021
Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. Bioorganic & medicinal chemistry, 2021, 04-01, Volume: 35 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Benzofurans; Benzylidene Compounds; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Copper; Dose-Response Relationship, Drug; Electrophorus; Female; Humans; Male; Mannich Bases; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Structure; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Protein Aggregates; Rats; Structure-Activity Relationship	2021
Twin drug design, synthesis and evaluation of diosgenin derivatives as multitargeted agents for the treatment of vascular dementia. Bioorganic & medicinal chemistry, 2021, 05-01, Volume: 37 Topics: Acetylcholinesterase; Animals; Cell Survival; Central Nervous System Agents; Cholinesterase Inhibitors; Dementia, Vascular; Diosgenin; Humans; Kelch-Like ECH-Associated Protein 1; Learning; Male; Memory; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotection; NF-E2-Related Factor 2; Protective Agents; Protein Binding; Rats, Sprague-Dawley; Reactive Oxygen Species	2021
Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant. European journal of medicinal chemistry, 2021, Oct-15, Volume: 222 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Benzofurans; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; Piperidines; Protein Aggregates; Protein Aggregation, Pathological; Structure-Activity Relationship	2021
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease. European journal of medicinal chemistry, 2021, Nov-05, Volume: 223 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cannabidiol; Carbamates; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Drug Design; Humans; Kinetics; Maze Learning; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotective Agents; Structure-Activity Relationship	2021
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT European journal of medicinal chemistry, 2021, Dec-05, Volume: 225 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Proliferation; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Electrophorus; Hep G2 Cells; Horses; Humans; Indoles; Ligands; Mice; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Protein Aggregates; Receptors, Serotonin; Structure-Activity Relationship; tau Proteins	2021
Development of novel 2-aminoalkyl-6-(2-hydroxyphenyl)pyridazin-3(2H)-one derivatives as balanced multifunctional agents against Alzheimer's disease. European journal of medicinal chemistry, 2022, Feb-15, Volume: 230 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cholinesterase Inhibitors; Drug Design; Mice; Protein Aggregates; Structure-Activity Relationship	2022
Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease. Bioorganic & medicinal chemistry letters, 2022, 03-15, Volume: 60 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Copper; Dose-Response Relationship, Drug; Drug Development; Flavanones; Humans; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Rats; Structure-Activity Relationship	2022
Synthesis, biological evaluation, and molecular modeling simulations of new heterocyclic hybrids as multi-targeted anti-Alzheimer's agents. European journal of medicinal chemistry, 2022, Mar-05, Volume: 231 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cholinesterase Inhibitors; Donepezil; Drug Design; Humans; Models, Molecular; Neuroprotective Agents; Tacrine	2022
Alzheimer's disease: new pharmacological perspectives. Methods and findings in experimental and clinical pharmacology, 1996, Volume: 18 Suppl B Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Dihydropyridines; Donepezil; Humans; Indans; Muscarinic Agonists; Oximes; Phenylcarbamates; Piperidines; Pyridines; Rivastigmine; Tacrine; Thiadiazoles	1996
[Drug therapy strategies in Alzheimer's disease]. La Revue du praticien, 1998, Nov-01, Volume: 48, Issue:17 Topics: Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Depression; Donepezil; Humans; Indans; Mental Disorders; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Sleep Wake Disorders; Tacrine	1998
[Alzheimer's disease. Foreword]. La Revue du praticien, 1998, Nov-01, Volume: 48, Issue:17 Topics: Age Factors; Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	1998
Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats. European journal of pharmacology, 1999, Sep-10, Volume: 380, Issue:2-3 Topics: Acetylcholine; Acetylcholinesterase; Administration, Oral; Animals; Brain; Carbamates; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Extracellular Space; Hippocampus; Indans; Male; Phenylcarbamates; Piperidines; Rats; Rats, Wistar; Rivastigmine; Tacrine	1999
Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats. Japanese journal of pharmacology, 1999, Volume: 81, Issue:2 Topics: Animals; Benzazepines; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Donepezil; Electrochemistry; Extracellular Space; Indans; Male; Microdialysis; Nootropic Agents; Peripheral Nervous System; Phenylcarbamates; Piperidines; Rats; Rats, Wistar; Rivastigmine; Tacrine	1999
New drugs for Alzheimer's disease. The British journal of psychiatry : the journal of mental science, 1999, Volume: 174 Topics: Alzheimer Disease; Carbamates; Donepezil; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Rivastigmine; Tacrine	1999
Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. European journal of pharmacology, 2000, Feb-18, Volume: 389, Issue:2-3 Topics: Administration, Oral; Alzheimer Disease; Animals; Benzazepines; Brain; Carbamates; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Indans; Learning; Male; Memory; Phenylcarbamates; Piperidines; Rats; Rats, Wistar; Rivastigmine; Tacrine	2000
Relation between cholinesterase inhibitor and Pisa syndrome. Lancet (London, England), 2000, Jun-24, Volume: 355, Issue:9222 Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Dopamine Antagonists; Dystonia; Female; Humans; Indans; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Posture; Psychomotor Agitation; Risperidone; Rivastigmine; Syndrome	2000
The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:10 Topics: Aged; Alzheimer Disease; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Receptors, Nicotinic; Rivastigmine; Tacrine	2000
The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:11 Topics: Alzheimer Disease; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Receptors, Nicotinic; Rivastigmine	2000
Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat. Journal of psychopharmacology (Oxford, England), 2000, Volume: 14, Issue:3 Topics: Animals; Body Temperature; Carbamates; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Hypothermia; Indans; Lacrimal Apparatus; Male; Phenylcarbamates; Piperidines; Rats; Rivastigmine; Saliva; Tacrine; Tremor; Trichlorfon	2000
Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:8 Topics: Acetylcholinesterase; Alzheimer Disease; Aminoquinolines; Animals; Benzazepines; Brain; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Donepezil; In Vitro Techniques; Indans; Inhibitory Concentration 50; Male; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rivastigmine; Tacrine; Time Factors	2000
Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine. Clinical therapeutics, 2001, Volume: 23 Suppl A Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Interactions; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Sleep	2001
Medications for the treatment of Alzheimer's disease. The Journal of the Oklahoma State Medical Association, 2001, Volume: 94, Issue:8 Topics: Alzheimer Disease; Antioxidants; Carbamates; Cholinesterase Inhibitors; Donepezil; Estrogen Replacement Therapy; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2001
Featured CME topic: dementia. Medication update. Southern medical journal, 2001, Volume: 94, Issue:7 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Contraindications; Donepezil; Drug Interactions; Ergoloid Mesylates; Galantamine; Ginkgo biloba; Humans; Indans; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Plants, Medicinal; Rivastigmine	2001
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. Mechanisms of ageing and development, 2001, Volume: 122, Issue:16 Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Administration Schedule; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Protein Isoforms; Rivastigmine; Time Factors	2001
Maintaining functional and behavioral abilities in Alzheimer disease. Alzheimer disease and associated disorders, 2001, Volume: 15 Suppl 1 Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Galantamine; Humans; Indans; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine; Treatment Outcome	2001
[Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko]. MMW Fortschritte der Medizin, 2001, Dec-13, Volume: 143, Issue:51-52 Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Confidence Intervals; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Neuroprotective Agents; Nootropic Agents; Parasympathomimetics; Phenylcarbamates; Phytotherapy; Piperidines; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Rivastigmine	2001
Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it? International journal of geriatric psychiatry, 2002, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Treatment Outcome; United Kingdom	2002
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials. Neurologia i neurochirurgia polska, 2001, Volume: 35 Suppl 3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Carbamates; Cholinesterase Inhibitors; Cognition; Donepezil; Evaluation Studies as Topic; Event-Related Potentials, P300; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Piperidines; Reaction Time; Rivastigmine; Sensitivity and Specificity; Severity of Illness Index; Tacrine	2001
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:7-8 Topics: Acetylcholine; Aging; Animals; Body Weight; Brain; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Drug Administration Schedule; Hippocampus; Indans; Male; Muscarinic Antagonists; Phenylcarbamates; Piperidines; Pirenzepine; Rats; Rats, Inbred F344; Rivastigmine; Trichlorfon	2002
Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Aged; Alzheimer Disease; Brain; Carbamates; Case-Control Studies; Cerebrovascular Circulation; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Follow-Up Studies; Humans; Indans; Male; Phenylcarbamates; Piperidines; Radiopharmaceuticals; Rivastigmine; Technetium Tc 99m Exametazime; Time Factors; Tomography, Emission-Computed, Single-Photon	2002
Fatal aspiration pneumonia during transition from donepezil to rivastigmine. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:10 Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Administration Schedule; Fatal Outcome; Humans; Indans; Male; Phenylcarbamates; Piperidines; Pneumonia, Aspiration; Rivastigmine	2002
The impact of journal advertisements on prescribers of cholinesterase inhibitors. International journal of geriatric psychiatry, 2002, Volume: 17, Issue:10 Topics: Advertising; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Prescriptions; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Publishing; Random Allocation; Rivastigmine	2002
Comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil. Current medical research and opinion, 2002, Volume: 18, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Donepezil; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Reproducibility of Results; Research Design; Rivastigmine	2002
Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. European journal of pharmacology, 2002, Nov-29, Volume: 455, Issue:2-3 Topics: Acetylcholinesterase; Alkaloids; Animals; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Donepezil; Hippocampus; Indans; Isoenzymes; Kinetics; Male; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine; Sesquiterpenes; Tacrine	2002
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. International clinical psychopharmacology, 2003, Volume: 18, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Middle Aged; Phenylcarbamates; Piperidines; Product Surveillance, Postmarketing; Rivastigmine; Surveys and Questionnaires; Tacrine; Treatment Outcome	2003
[Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office]. Fortschritte der Medizin. Originalien, 2002, Dec-05, Volume: 120, Issue:4 Topics: Aged; Alzheimer Disease; Brief Psychiatric Rating Scale; Carbamates; Cholinesterase Inhibitors; Dihydroergotoxine; Donepezil; Family Practice; Female; Follow-Up Studies; Galantamine; Ginkgo biloba; Humans; Indans; Male; Memantine; Neuroprotective Agents; Nimodipine; Nootropic Agents; Phenylcarbamates; Piperidines; Piracetam; Psychiatric Status Rating Scales; Risk Factors; Rivastigmine; Time Factors; Vasodilator Agents	2002
Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:3 Topics: Allosteric Regulation; Animals; Carbamates; Cells, Cultured; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Mice; Neurons; Phenylcarbamates; Piperidines; Receptors, Muscarinic; Receptors, Nicotinic; Recombinant Fusion Proteins; Rivastigmine; Tacrine; Trichlorfon	2003
Comparative study of donepezil and rivastigmine. International journal of clinical practice, 2003, Volume: 57, Issue:5 Topics: Carbamates; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2003
Editorial comment--How to treat vascular dementia? Stroke, 2003, Volume: 34, Issue:10 Topics: Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Treatment Outcome	2003
Pharmacologic treatment expectations in the management of dementia with Lewy bodies. Dementia and geriatric cognitive disorders, 2004, Volume: 17 Suppl 1 Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Brain; Carbamates; Cholinesterase Inhibitors; Diagnosis, Differential; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2004
No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment. Current medical research and opinion, 2003, Volume: 19, Issue:8 Topics: Aged; Alzheimer Disease; Carbamates; Donepezil; Female; Humans; Indans; Male; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Failure; Treatment Outcome	2003
A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease. Journal of Alzheimer's disease : JAD, 2003, Volume: 5, Issue:6 Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine	2003
Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke, 2004, Volume: 35, Issue:4 Topics: Carbamates; Cardiovascular Diseases; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine; Stroke; Terminology as Topic	2004
Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Neuroscience letters, 2004, May-06, Volume: 361, Issue:1-3 Topics: Acetylcholine; Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Brain Chemistry; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Fasciculation; Indans; Male; Neurons; Phenylcarbamates; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine; Sesquiterpenes; Up-Regulation	2004
A case study in the treatment of dementia with Lewy bodies. Acta psychiatrica Scandinavica, 2004, Volume: 110, Issue:1 Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galantamine; Hallucinations; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Agitation; Rivastigmine; Social Behavior	2004
Understanding the latest advances in pharmacologic interventions for Alzheimer's disease. CNS spectrums, 2004, Volume: 9, Issue:7 Suppl 5 Topics: Aged; Alzheimer Disease; Antioxidants; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Treatment Outcome	2004
Efficacy of acetylcholinesterase inhibitors in frontotemporal dementia. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:11 Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2004
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens. European journal of pharmacology, 2004, Oct-25, Volume: 503, Issue:1-3 Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Electric Stimulation; Galantamine; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Nicotinic Agonists; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Receptors, Purinergic; Rivastigmine; Stimulation, Chemical; Synaptic Transmission; Tacrine; Vas Deferens	2004
Switching from donepezil or rivastigmine to galantamine in clinical practice. Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:11 Topics: Alzheimer Disease; Donepezil; Galantamine; Humans; Indans; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine	2004
Impact of rivastigmine use on the risk of nursing home placement in a US sample. CNS drugs, 2004, Volume: 18, Issue:15 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cohort Studies; Databases, Factual; Donepezil; Drug Utilization Review; Female; Humans; Indans; Insurance; Male; Nursing Homes; Phenylcarbamates; Piperidines; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Rivastigmine; Time Factors; United States	2004
Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology, 2005, Volume: 180, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Galantamine; Humans; Indans; Male; Memantine; Mice; Mice, Mutant Strains; Phenylcarbamates; Piperidines; Rivastigmine; Sensitivity and Specificity	2005
Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia. Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:2 Topics: Aged; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Piperidines; Rivastigmine; Sweating	2005
NICE proposes to withdraw Alzheimer's drugs from NHS. BMJ (Clinical research ed.), 2005, Mar-05, Volume: 330, Issue:7490 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cost-Benefit Analysis; Donepezil; Drug Costs; England; Formularies as Topic; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Rivastigmine; State Medicine; Wales	2005
Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. Journal of managed care pharmacy : JMCP, 2005, Volume: 11, Issue:3 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cohort Studies; Donepezil; Drug Administration Schedule; Female; Humans; Indans; Male; Patient Dropouts; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine	2005
Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:7 Topics: Cholinesterase Inhibitors; Comorbidity; Cross-Over Studies; Cross-Sectional Studies; Dementia; Donepezil; Double-Blind Method; Humans; Indans; Mental Status Schedule; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2005
One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests. Human psychopharmacology, 2005, Volume: 20, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Psychomotor Performance; Rivastigmine	2005
Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease. Drugs & aging, 2005, Volume: 22, Issue:8 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors	2005
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3 Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine	2005
UK government guidance on Alzheimer's drugs postponed. Drug discovery today, 2005, Sep-01, Volume: 10, Issue:17 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cost-Benefit Analysis; Donepezil; Excitatory Amino Acid Antagonists; Federal Government; Galantamine; Government Regulation; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; United Kingdom	2005
Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs. International journal of geriatric psychiatry, 2006, Volume: 21, Issue:1 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; European Union; Galantamine; Humans; Indans; Memantine; Neurotransmitter Agents; Phenylcarbamates; Piperidines; Reimbursement Mechanisms; Rivastigmine	2006
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology. Current medical research and opinion, 2006, Volume: 22, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Double-Blind Method; Female; Humans; Indans; Lewy Body Disease; Male; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Retrospective Studies; Rivastigmine; Treatment Outcome	2006
Appeals system and its outcomes in national health insurance in Taiwan. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Donepezil; Female; Humans; Indans; Male; Middle Aged; National Health Programs; Negotiating; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Taiwan	2006
Pharmacological manipulation of the vasoconstrictive effects of amyloid-beta peptides by donepezil and rivastigmine. Current Alzheimer research, 2006, Volume: 3, Issue:2 Topics: Amyloid beta-Peptides; Animals; Donepezil; Hindlimb; Indans; Male; Peptide Fragments; Phenylcarbamates; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine; Vasoconstriction	2006
[Advances in Alzheimer's disease treatment]. La Revue de medecine interne, 2006, Volume: 27, Issue:8 Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Clinical Trials, Phase III as Topic; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Placebos; Randomized Controlled Trials as Topic; Rivastigmine	2006
[Cholinesterase inhibitor therapy in long term care settings]. La Revue de medecine interne, 2006, Volume: 27, Issue:8 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Follow-Up Studies; Galantamine; Humans; Indans; Long-Term Care; Neuroprotective Agents; Nootropic Agents; Patient Selection; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Time Factors	2006
Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis. The American journal of geriatric pharmacotherapy, 2006, Volume: 4, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Utilization; Female; Galantamine; Homes for the Aged; Humans; Indans; Male; Middle Aged; Nursing Homes; Phenylcarbamates; Piperidines; Polypharmacy; Retrospective Studies; Rivastigmine	2006
Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats. Acta pharmacologica Sinica, 2006, Volume: 27, Issue:9 Topics: Acetylcholine; Administration, Oral; Alkaloids; Animals; Brain; Cholinesterase Inhibitors; Donepezil; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Indans; Male; Neuroprotective Agents; Norepinephrine; Phenylcarbamates; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Rivastigmine; Serotonin; Sesquiterpenes	2006
Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes. Rapid communications in mass spectrometry : RCM, 2006, Volume: 20, Issue:22 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Donepezil; Doping in Sports; Ethylamines; Female; Galantamine; Growth Hormone; Humans; Indans; Indoles; Phenylcarbamates; Piperidines; Rivastigmine; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry; Urinalysis	2006
The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. British journal of pharmacology, 2006, Volume: 149, Issue:8 Topics: Amnesia; Amyloid beta-Peptides; Animals; Avoidance Learning; Behavior, Animal; Donepezil; Dose-Response Relationship, Drug; Ethylenediamines; Fluorescent Dyes; Galantamine; Indans; Injections, Intraventricular; Lipid Peroxidation; Male; Maze Learning; Mice; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Phenols; Phenylcarbamates; Piperidines; Receptors, sigma; Rivastigmine; Sulfoxides; Xylenes	2006
Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients. Drug safety, 2006, Volume: 29, Issue:11 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Chronic Disease; Cross-Over Studies; Donepezil; Female; Galantamine; Humans; Indans; Logistic Models; Male; Phenylcarbamates; Piperidines; Respiratory Tract Diseases; Rivastigmine	2006
Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:9 Topics: Aged; Analysis of Variance; Cholinesterase Inhibitors; Clinical Trials as Topic; Data Interpretation, Statistical; Donepezil; Female; Galantamine; Humans; Indans; Lewy Body Disease; Male; Neuropsychological Tests; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome	2007
Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl). Archives of gerontology and geriatrics, 2007, Volume: 44 Suppl 1 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Donepezil; Female; Follow-Up Studies; Galantamine; Humans; Indans; Male; Mental Disorders; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Severity of Illness Index	2007
Effect of anti-dementia drugs on LPS induced neuroinflammation in mice. Life sciences, 2007, May-01, Volume: 80, Issue:21 Topics: Acetylcholinesterase; Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Indans; Inflammation; Injections, Intraperitoneal; Interleukin-2; Lipopolysaccharides; Mice; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2007
Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease. Journal of the American Geriatrics Society, 2007, Volume: 55, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Rivastigmine; Urinary Incontinence	2007
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology, 2007, May-15, Volume: 68, Issue:20 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Autopsy; Cerebral Cortex; Cholinesterase Inhibitors; Clinical Trials as Topic; Cohort Studies; Donepezil; Drug Evaluation; Female; Galantamine; Humans; Indans; Lewy Body Disease; Male; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Piperidines; Prospective Studies; Rivastigmine; Tacrine; tau Proteins; Tauopathies	2007
Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study. Neurology, 2007, Jul-03, Volume: 69, Issue:1 Topics: Adaptation, Physiological; Aged; Alzheimer Disease; Brain Mapping; Cerebrovascular Circulation; Cholinesterase Inhibitors; Donepezil; Female; Frontal Lobe; Hippocampus; Humans; Indans; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Nootropic Agents; Oxygen Radioisotopes; Pattern Recognition, Visual; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Rivastigmine; Temporal Lobe	2007
N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine. European journal of pharmacology, 2007, Oct-31, Volume: 572, Issue:2-3 Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cerebral Cortex; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Indans; Male; Mass Spectrometry; Microdialysis; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Rivastigmine	2007
Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:2 Topics: Activities of Daily Living; Aged, 80 and over; Alzheimer Disease; Assisted Living Facilities; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Administration Schedule; Female; Galantamine; Health Surveys; Homes for the Aged; Humans; Indans; Male; Mental Status Schedule; Neuropsychological Tests; Phenylcarbamates; Piperidines; Retention, Psychology; Rivastigmine; Survival Analysis; Treatment Outcome	2008
Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors. Acta bio-medica : Atenei Parmensis, 2007, Volume: 78, Issue:1 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine	2007
Evaluation of centrally acting cholinesterase inhibitor exposures in adults. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Poison Control Centers; Retrospective Studies; Rivastigmine; Tacrine	2007
NICE judgement leaves behind a nasty taste. Nursing older people, 2007, Volume: 19, Issue:7 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Disease Progression; Donepezil; Formularies as Topic; Galantamine; Humans; Indans; Insurance, Health, Reimbursement; Insurance, Pharmaceutical Services; Jurisprudence; Phenylcarbamates; Piperidines; Rivastigmine; State Medicine; Time Factors; United Kingdom	2007
Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). Drug safety, 2007, Volume: 30, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Databases, Factual; Donepezil; Drug Interactions; Female; Formularies as Topic; France; Galantamine; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Rivastigmine; United Kingdom	2007
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study. Psychiatry and clinical neurosciences, 2007, Volume: 61, Issue:6 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Behavior; Benzodiazepines; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Donepezil; Endpoint Determination; Female; Galantamine; Humans; Indans; Long-Term Care; Male; Neuropsychological Tests; Nootropic Agents; Olanzapine; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Rivastigmine; Treatment Outcome	2007
Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Annals of internal medicine, 2008, Mar-04, Volume: 148, Issue:5 Topics: Activities of Daily Living; Affect; Cholinesterase Inhibitors; Cognition; Dementia; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Quality of Life; Rivastigmine; Tacrine	2008
Estimated pre-morbid IQ effects on cognitive and functional outcomes in Alzheimer disease: a longitudinal study in a treated cohort. BMC psychiatry, 2008, Apr-21, Volume: 8 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cognition; Donepezil; Female; Follow-Up Studies; Humans; Indans; Intelligence; Intelligence Tests; Learning; Longitudinal Studies; Male; Neuroprotective Agents; Nootropic Agents; Patient Compliance; Phenylcarbamates; Piperidines; Prognosis; Reading; Rivastigmine; Self Care; Speech	2008
Dementia medications in palliative care #174. Journal of palliative medicine, 2008, Volume: 11, Issue:4 Topics: Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Palliative Care; Phenylcarbamates; Piperidines; Prognosis; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2008
AAFP and ACP release guideline on dementia treatment. American family physician, 2008, Apr-15, Volume: 77, Issue:8 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Guidelines as Topic; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine	2008
Prevalence of cholinesterase inhibitors in subjects with dementia in Europe. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:7 Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Europe; Galantamine; Health Policy; Humans; Indans; Insurance, Health, Reimbursement; Phenylcarbamates; Piperidines; Practice Patterns, Physicians'; Prevalence; Rivastigmine	2008
Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease. Journal of managed care pharmacy : JMCP, 2008, Volume: 14, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Databases, Factual; Donepezil; Drug Costs; Female; Follow-Up Studies; Galantamine; Health Care Costs; Humans; Indans; Male; Multivariate Analysis; Patient Compliance; Phenylcarbamates; Piperidines; Practice Patterns, Physicians'; Retrospective Studies; Rivastigmine	2008
Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro. Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:10 Topics: Animals; Brain; Cells, Cultured; Cholinesterase Inhibitors; Donepezil; Galantamine; In Vitro Techniques; Indans; Male; Neurons; PC12 Cells; Phenylcarbamates; Piperidines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Rivastigmine	2008
Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2009, Jun-05, Volume: 150B, Issue:4 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Butyrylcholinesterase; Case-Control Studies; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Donepezil; Female; Gene Frequency; Genotype; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Polymorphism, Single Nucleotide; Rivastigmine	2009
[Alzheimer type dementia]. Revue de l'infirmiere, 2008, Issue:143 Topics: Alzheimer Disease; Apolipoprotein E4; Diagnosis, Differential; Disease Progression; Donepezil; Humans; Indans; Memantine; Neuroprotective Agents; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine	2008
Drug utilization review of cholinesterase inhibitors in Quebec. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2008, Volume: 35, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Utilization Review; Galantamine; Humans; Indans; Middle Aged; Phenylcarbamates; Piperidines; Quebec; Rivastigmine	2008
Adherence to cholinesterase inhibitors in patients with Alzheimer's disease. Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:2 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Medication Adherence; Middle Aged; Phenylcarbamates; Piperidines; Rivastigmine	2009
Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines. Translational research : the journal of laboratory and clinical medicine, 2009, Volume: 153, Issue:3 Topics: Acetylcholinesterase; Cell Line; Cholinesterase Inhibitors; DNA; DNA-Binding Proteins; Donepezil; Galantamine; Gene Expression Regulation; Heat Shock Transcription Factors; Heat-Shock Response; HSP70 Heat-Shock Proteins; Humans; Indans; Macrophages; Neurons; Phenylcarbamates; Phosphorylation; Piperidines; Protein Binding; Regulatory Sequences, Nucleic Acid; Rivastigmine; RNA, Messenger; Time Factors; Transcription Factors	2009
Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex. Journal of Alzheimer's disease : JAD, 2009, Volume: 16, Issue:3 Topics: Acetylcholine; Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Galantamine; Humans; In Vitro Techniques; Indans; Middle Aged; Neocortex; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Rivastigmine; Tacrine; Young Adult	2009
Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease. Neuroreport, 2009, Feb-18, Volume: 20, Issue:3 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cholinesterase Inhibitors; Cytoprotection; Disease Progression; Donepezil; Drug Synergism; Drug Therapy, Combination; Female; Galantamine; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Neural Pathways; Neuroprotective Agents; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2009
Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2009, Volume: 12, Issue:1 Topics: Acetylcholine; Acetylcholinesterase; Animals; Brain; Cholinesterase Inhibitors; Donepezil; Female; Hippocampus; Indans; Male; Mice; Mice, Knockout; Microdialysis; Phenylcarbamates; Piperidines; Rivastigmine	2009
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil. Journal of medical economics, 2009, Volume: 12, Issue:2 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Disease Progression; Donepezil; Female; Forecasting; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Nursing Homes; Patient Transfer; Phenylcarbamates; Piperidines; Proportional Hazards Models; Prospective Studies; Psychometrics; Randomized Controlled Trials as Topic; Risk Assessment; Rivastigmine; Severity of Illness Index	2009
Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study. Drugs & aging, 2009, Volume: 26, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Databases, Factual; Delayed-Action Preparations; Dementia; Donepezil; Follow-Up Studies; Galantamine; Humans; Indans; Medication Adherence; Phenylcarbamates; Piperidines; Rivastigmine	2009
Drug-induced sialorrhoea and excessive saliva accumulation. Prescrire international, 2009, Volume: 18, Issue:101 Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; Donepezil; Galantamine; Humans; Hypnotics and Sedatives; Indans; Phenylcarbamates; Pilocarpine; Piperidines; Quality of Life; Risperidone; Rivastigmine; Sialorrhea	2009
International price comparisons of Alzheimer's drugs: a way to close the affordability gap. International psychogeriatrics, 2009, Volume: 21, Issue:6 Topics: Aged; Alzheimer Disease; Cross-Cultural Comparison; Developing Countries; Donepezil; Drug Costs; Economics; Galantamine; Humans; Income; Indans; India; Memantine; Mexico; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; United States	2009
Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? Dementia and geriatric cognitive disorders, 2009, Volume: 28, Issue:3 Topics: Aged; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cross-Sectional Studies; Donepezil; Excitatory Amino Acid Antagonists; Female; Galantamine; Humans; Indans; Male; Memantine; Middle Aged; Neuropsychological Tests; Nootropic Agents; Patient Compliance; Patient Satisfaction; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Rivastigmine; Socioeconomic Factors; Spain; Surveys and Questionnaires	2009
Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:3 Topics: Acetylcholinesterase; Alkaloids; Animals; Antidotes; Chemical Warfare Agents; Donepezil; Dose-Response Relationship, Drug; Galantamine; Guinea Pigs; Indans; Lethal Dose 50; Male; Phenylcarbamates; Piperidines; Poisoning; Rivastigmine; Sesquiterpenes; Soman; Time Factors; Toxicity Tests, Acute	2009
Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect. The Journal of neuropsychiatry and clinical neurosciences, 2009,Summer, Volume: 21, Issue:3 Topics: Aged; Aspartic Acid; Brain; Cognition Disorders; Dementia; Donepezil; Female; Humans; Indans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome	2009
Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:11 Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Heart Rate; Hospitals, Veterans; Humans; Incidence; Indans; Massachusetts; Nootropic Agents; Phenylcarbamates; Piperidines; Risk; Rivastigmine; Veterans	2009
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study. CNS drugs, 2010, Volume: 24, Issue:2 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Apolipoproteins E; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Galantamine; Genetic Variation; Genotype; Humans; Indans; Italy; Male; Outcome Assessment, Health Care; Phenylcarbamates; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome	2010
Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2010, Volume: 6, Issue:5 Topics: Alzheimer Disease; Analysis of Variance; Blood Cells; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Galantamine; Gene Expression Regulation; Genome-Wide Association Study; Humans; Indans; Microarray Analysis; Phenylcarbamates; Piperidines; Principal Component Analysis; Rivastigmine; RNA	2010
Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease. Dementia and geriatric cognitive disorders, 2010, Volume: 29, Issue:3 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Comorbidity; Donepezil; Drug Utilization; Female; Galantamine; Geriatric Assessment; Humans; Indans; Male; Memantine; Middle Aged; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Psychotropic Drugs; Rivastigmine; Socioeconomic Factors	2010
Anticholinesterase duration in the Australian veteran population. The Australian and New Zealand journal of psychiatry, 2010, Volume: 44, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Australia; Cholinesterase Inhibitors; Donepezil; Female; Follow-Up Studies; Galantamine; Humans; Indans; Male; Medication Adherence; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Time Factors; Treatment Outcome; Veterans	2010
Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. The Gerontologist, 2011, Volume: 51, Issue:1 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Galantamine; Humans; Indans; Kaplan-Meier Estimate; Male; Middle Aged; Nursing Homes; Phenylcarbamates; Piperidines; Proportional Hazards Models; Prospective Studies; Risk Factors; Rivastigmine; Severity of Illness Index; Sex Factors; Sweden	2011
How do we treat people with dementia in Croatia. Psychiatria Danubina, 2010, Volume: 22, Issue:2 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Croatia; Cross-Cultural Comparison; Cross-Sectional Studies; Donepezil; Drug Approval; Drug Costs; Humans; Indans; Memantine; National Health Programs; Nootropic Agents; Phenylcarbamates; Piperidines; Reimbursement Mechanisms; Rivastigmine	2010
Predictors of adherence among Alzheimer's disease patients receiving oral therapy. Current medical research and opinion, 2010, Volume: 26, Issue:8 Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Donepezil; Dopamine Agents; Female; Galantamine; Humans; Indans; Insurance Claim Review; Logistic Models; Male; Medication Adherence; Memantine; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Predictive Value of Tests; Retrospective Studies; Rivastigmine; Treatment Outcome	2010
[Variability and trends in dementia drug consumption in Castile-La Mancha (Spain). Estimated prevalence of Alzheimer's disease]. Neurologia (Barcelona, Spain), 2010, Volume: 25, Issue:4 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Dopamine Agents; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Observer Variation; Phenylcarbamates; Piperidines; Plant Extracts; Rivastigmine; Spain; Substance-Related Disorders	2010
Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study. Drugs & aging, 2010, Nov-01, Volume: 27, Issue:11 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cohort Studies; Databases, Factual; Dementia; Donepezil; Female; Humans; Indans; Male; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Time Factors	2010
Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability. International journal of geriatric psychiatry, 2011, Volume: 26, Issue:3 Topics: Alzheimer Disease; Cardiovascular Diseases; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Multivariate Analysis; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine	2011
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions: Evidence is not satisfactory. Deutsches Arzteblatt international, 2011, Volume: 108, Issue:8 Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Evidence-Based Medicine; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine	2011
[Prescription differences of dementia drugs in urban and rural areas in Germany]. Psychiatrische Praxis, 2011, Volume: 38, Issue:5 Topics: Aged; Alzheimer Disease; Ambulatory Care; Donepezil; Galantamine; General Practice; Germany; Humans; Indans; Medically Underserved Area; Memantine; Neuropsychiatry; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Patterns, Physicians'; Rivastigmine; Rural Population; Urban Population; Workforce	2011
BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors. European journal of clinical pharmacology, 2011, Volume: 67, Issue:11 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognition; Cytochrome P-450 CYP2D6; Donepezil; Female; Galantamine; Genetic Association Studies; Genetic Variation; Genotype; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Rivastigmine; Treatment Outcome	2011
Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account. Prescrire international, 2011, Volume: 20, Issue:115 Topics: Alzheimer Disease; Bradycardia; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk; Rivastigmine	2011
Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice. Behavioural brain research, 2011, Nov-20, Volume: 225, Issue:1 Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognition Disorders; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Indans; Male; Mice; Mice, Inbred ICR; Motor Activity; Peptide Fragments; Phenylcarbamates; Piperidines; Recognition, Psychology; Rivastigmine	2011
Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease. Dementia and geriatric cognitive disorders, 2011, Volume: 32, Issue:1 Topics: Aged; Alzheimer Disease; Apolipoproteins E; Aryldialkylphosphatase; Cholinesterase Inhibitors; DNA; Donepezil; Female; Haplotypes; Heterozygote; Humans; Indans; Male; Neuropsychological Tests; Phenylcarbamates; Piperidines; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; Rivastigmine	2011
Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011, Volume: 19, Issue:9 Topics: Aged; Aged, 80 and over; Anesthesia, General; Cholinesterase Inhibitors; Cohort Studies; Critical Care; Dementia; Donepezil; Female; Galantamine; Hip Fractures; Humans; Indans; Male; Outcome and Process Assessment, Health Care; Phenylcarbamates; Piperidines; Pneumonia; Postoperative Complications; Respiratory Insufficiency; Resuscitation; Risk; Rivastigmine	2011
Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine. Behavioural pharmacology, 2011, Volume: 22, Issue:1 Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cocaine; Donepezil; Dopamine Uptake Inhibitors; Female; Indans; Male; Phenylcarbamates; Piperidines; Rats; Rats, Wistar; Reinforcement, Psychology; Rivastigmine; Self Administration	2011
Pisa syndrome secondary to rivastigmine: a case report. La Clinica terapeutica, 2012, Volume: 163, Issue:1 Topics: Aged; Benzodiazepines; Cholinesterase Inhibitors; Delusions; Dementia; Donepezil; Humans; Indans; Male; Movement Disorders; Olanzapine; Phenylcarbamates; Piperidines; Posture; Rivastigmine; Syndrome	2012
Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS. Journal of pharmaceutical and biomedical analysis, 2012, Volume: 64-65 Topics: Chromatography, High Pressure Liquid; Donepezil; Drug Stability; Galantamine; Humans; Indans; Memantine; Nootropic Agents; Phenethylamines; Phenols; Phenylcarbamates; Piperidines; Plasma; Reference Standards; Reproducibility of Results; Rivastigmine; Tandem Mass Spectrometry	2012
Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors. Journal of Alzheimer's disease : JAD, 2012, Volume: 30, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Catalase; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Glutathione Reductase; Humans; Indans; Male; Oxidative Stress; Phenylcarbamates; Piperidines; Rivastigmine	2012
Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012, Volume: 27, Issue:7 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Body Mass Index; Case-Control Studies; Cholinesterase Inhibitors; Donepezil; Female; Hip Fractures; Humans; Indans; Male; Odds Ratio; Phenylcarbamates; Piperidines; Regression Analysis; Risk; Rivastigmine	2012
Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease? American journal of Alzheimer's disease and other dementias, 2012, Volume: 27, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Pressure; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Heart; Humans; Indans; Male; Phenylcarbamates; Piperidines; Rivastigmine	2012
Trace analysis of acetylcholinesterase inhibitors with antipsychotic drugs for Alzheimer's disease by capillary electrophoresis with on column field-amplified sample injection. Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:10 Topics: Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Donepezil; Electrophoresis, Capillary; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine	2013
Is drug treatment for dementia followed up in primary care? A Swedish study of dementia clinics and referring primary care centres. PloS one, 2013, Volume: 8, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Medical Records; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Retrospective Studies; Rivastigmine; Sweden; Treatment Outcome	2013
Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors. International journal of geriatric psychiatry, 2013, Volume: 28, Issue:12 Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cholinesterase Inhibitors; Donepezil; Enzyme-Linked Immunosorbent Assay; Female; Galantamine; Humans; Indans; Interleukin-1beta; Interleukin-6; Male; Phenylcarbamates; Piperidines; Rivastigmine; Sex Factors; Tumor Necrosis Factor-alpha	2013
A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy. Clinical interventions in aging, 2013, Volume: 8 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Chi-Square Distribution; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Home Care Services; Humans; Indans; Linear Models; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Piperidines; Proportional Hazards Models; Prospective Studies; Risk Factors; Rivastigmine; Treatment Outcome	2013
Utility of an effect size analysis for communicating treatment effectiveness: a case study of cholinesterase inhibitors for Alzheimer's disease. Journal of the American Geriatrics Society, 2013, Volume: 61, Issue:7 Topics: Aged; Alzheimer Disease; Area Under Curve; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome	2013
[Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina]. Medicina, 2013, Volume: 73, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Argentina; Child; Child, Preschool; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Dementia, Vascular; Donepezil; Drug Prescriptions; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Middle Aged; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Young Adult	2013
Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease. International journal of geriatric psychiatry, 2014, Volume: 29, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brief Psychiatric Rating Scale; Cholinesterase Inhibitors; Donepezil; Estrogen Receptor alpha; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Polymorphism, Single Nucleotide; Rivastigmine; Sex Factors	2014
Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity. The American journal of emergency medicine, 2014, Volume: 32, Issue:7 Topics: Aged; Bradycardia; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Humans; Indans; Lewy Body Disease; Male; Miosis; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine	2014
Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. International clinical psychopharmacology, 2014, Volume: 29, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Donepezil; Drug Monitoring; Drug Prescriptions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Finland; Follow-Up Studies; Galantamine; Guideline Adherence; Humans; Indans; Male; Memantine; Nootropic Agents; Phenylcarbamates; Piperidines; Practice Guidelines as Topic; Proportional Hazards Models; Registries; Rivastigmine	2014
Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats. Behavioural brain research, 2014, Jul-15, Volume: 268 Topics: Animals; Cholinesterase Inhibitors; Conditioning, Psychological; Donepezil; Drug-Seeking Behavior; Indans; Male; Mecamylamine; Morphine; Motor Activity; Muscarinic Antagonists; Narcotics; Nicotinic Antagonists; Phenylcarbamates; Piperidines; Rats, Wistar; Rivastigmine; Scopolamine; Space Perception	2014
Anti-dementia drugs in a psychiatric hospital for dementia patients. Geriatrics & gerontology international, 2014, Volume: 14, Issue:3 Topics: Aged; Dementia; Donepezil; Galantamine; Hospitalization; Hospitals, Psychiatric; Humans; Indans; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine	2014
Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential. Neuropharmacology, 2014, Volume: 86 Topics: Animals; Cerebral Cortex; Cognition; Donepezil; Drug Evaluation, Preclinical; Electrodes, Implanted; Electroencephalography; Galantamine; Gamma Rhythm; Indans; Male; Memantine; Motor Activity; Muscarinic Antagonists; Neural Pathways; Nootropic Agents; Phenylcarbamates; Piperidines; Principal Component Analysis; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Signal Processing, Computer-Assisted; Tacrine; Theta Rhythm	2014
FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease. Clinical interventions in aging, 2014, Volume: 9 Topics: Aged; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Donepezil; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Galantamine; Gene Frequency; Genetic Loci; Genotype; Haplotypes; Humans; Indans; Male; Oxidative Stress; Phenylcarbamates; Piperidines; Prospective Studies; Rivastigmine	2014
Galantamine improves sleep quality in patients with dementia. Acta neurologica Belgica, 2015, Volume: 115, Issue:4 Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Indans; Male; Piperidines; Rivastigmine; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome	2015
Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats. ACS chemical neuroscience, 2015, May-20, Volume: 6, Issue:5 Topics: Aging; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Cholinesterase Inhibitors; Donepezil; Enzyme-Linked Immunosorbent Assay; Indans; Liver; Male; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine	2015
Risk of pneumonia in new users of cholinesterase inhibitors for dementia. Journal of the American Geriatrics Society, 2015, Volume: 63, Issue:5 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cohort Studies; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Male; Phenylcarbamates; Piperidines; Pneumonia; Retrospective Studies; Risk Assessment; Rivastigmine	2015
The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada. BMC neurology, 2015, Apr-28, Volume: 15 Topics: Aged; Cholinesterase Inhibitors; Comorbidity; Databases, Factual; Dementia; Donepezil; Female; Galantamine; Health Services Research; Humans; Indans; Male; Ontario; Pacemaker, Artificial; Piperidines; Prosthesis Implantation; Retrospective Studies; Risk; Rivastigmine	2015
Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use. BMC health services research, 2015, May-22, Volume: 15 Topics: Aged; Aged, 80 and over; Caregivers; Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; Female; Galantamine; Germany; Humans; Indans; Interviews as Topic; Logistic Models; Male; Memantine; Neuroprotective Agents; Nootropic Agents; Piperidines; Rivastigmine	2015
The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan. PloS one, 2015, Volume: 10, Issue:6 Topics: Cohort Studies; Dementia; Dihydroergocristine; Dihydroergotamine; Donepezil; Galantamine; Humans; Indans; Memantine; Neuroprotective Agents; Nootropic Agents; Piperidines; Piracetam; Proportional Hazards Models; Retrospective Studies; Rivastigmine; Taiwan; Time Factors	2015
Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase. The Annals of pharmacotherapy, 2015, Volume: 49, Issue:11 Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Galantamine; Humans; Indans; Male; Medication Errors; North America; Pharmacovigilance; Piperidines; Rivastigmine; World Health Organization	2015
Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS). Journal of Alzheimer's disease : JAD, 2015, Volume: 48, Issue:3 Topics: Aged, 80 and over; Alzheimer Disease; Donepezil; Female; Humans; Indans; Male; Mental Status Schedule; Nootropic Agents; Piperidines; Psychiatric Status Rating Scales; Retrospective Studies; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome	2015
Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS). Journal of Alzheimer's disease : JAD, 2015, Volume: 46, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Donepezil; Female; Follow-Up Studies; Galantamine; Humans; Indans; Japan; Male; Memantine; Piperidines; Retrospective Studies; Rivastigmine; Treatment Outcome	2015
Real-world evaluation of compliance and preference in Alzheimer's disease treatment. Clinical interventions in aging, 2015, Volume: 10 Topics: Administration, Cutaneous; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Asia; Attitude of Health Personnel; Caregivers; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Medication Adherence; Memantine; Middle East; Patient Preference; Physicians; Piperidines; Prospective Studies; Rivastigmine	2015
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. PloS one, 2015, Volume: 10, Issue:12 Topics: Adverse Drug Reaction Reporting Systems; Alzheimer Disease; Canada; Cholinesterase Inhibitors; Databases, Factual; Dementia; Donepezil; Galantamine; Humans; Indans; Pharmacovigilance; Piperidines; Rivastigmine; United States; United States Food and Drug Administration	2015
Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina. Molecules (Basel, Switzerland), 2016, Jan-11, Volume: 21, Issue:1 Topics: Animals; Cholinesterase Inhibitors; Convulsants; Donepezil; Galantamine; Indans; Locomotion; Models, Biological; Piperidines; Planarians; Rivastigmine; Seizures; Survival Rate; Tacrine	2016
Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats. Psychopharmacology, 2016, Volume: 233, Issue:7 Topics: Anhedonia; Animals; Antidepressive Agents; Cholinesterase Inhibitors; Cognitive Dysfunction; Depressive Disorder; Disease Models, Animal; Donepezil; Indans; Male; Nootropic Agents; Piperidines; Rats; Rats, Wistar; Recognition, Psychology; Rivastigmine; Stress, Psychological	2016
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimer's research & therapy, 2016, Feb-17, Volume: 8 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Galantamine; Humans; Indans; Male; Mental Status Schedule; Piperidines; Prospective Studies; Rivastigmine; Severity of Illness Index; Treatment Outcome	2016
Characteristics of Pediatric Exposures to Antidementia Drugs Reported to a Poison Control System. The Journal of pediatrics, 2016, Volume: 172 Topics: Child; Child, Preschool; Dementia; Donepezil; Female; Galantamine; Humans; Indans; Infant; Male; Memantine; Nootropic Agents; Piperidines; Poison Control Centers; Retrospective Studies; Rivastigmine	2016
Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study. The journal of nutrition, health & aging, 2016, Volume: 20, Issue:4 Topics: Acetylcholinesterase; Activities of Daily Living; Aged; Body Mass Index; Body Weight; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Eating; Female; Follow-Up Studies; Galantamine; Geriatric Assessment; Humans; Indans; Male; Nutrition Assessment; Nutritional Status; Piperidines; Polypharmacy; Retrospective Studies; Rivastigmine	2016
Acquisition and reinstatement of ethanol-induced conditioned place preference in rats: Effects of the cholinesterase inhibitors donepezil and rivastigmine. Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:7 Topics: Animals; Cholinesterase Inhibitors; Conditioning, Psychological; Donepezil; Ethanol; Indans; Male; Mecamylamine; Muscarinic Antagonists; Nicotinic Antagonists; Piperidines; Rats; Rats, Wistar; Receptors, Nicotinic; Reinforcement, Psychology; Rivastigmine; Scopolamine	2016
Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats. Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:10 Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Ethanol; Indans; Male; Maze Learning; Memory Disorders; Motor Activity; Nootropic Agents; Piperidines; Rats, Wistar; Reaction Time; Rivastigmine; Rotarod Performance Test; Spatial Memory; Time Factors	2016
In Vitro Effects of Cognitives and Nootropics on Mitochondrial Respiration and Monoamine Oxidase Activity. Molecular neurobiology, 2017, Volume: 54, Issue:8 Topics: Alzheimer Disease; Animals; Brain; Cholinesterase Inhibitors; Cognition; Donepezil; Galantamine; Indans; Memantine; Mitochondria; Monoamine Oxidase; Nootropic Agents; Oxygen Consumption; Piperidines; Rivastigmine; Swine	2017
Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease. Annals of medicine, 2017, Volume: 49, Issue:3 Topics: Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Finland; Galantamine; Hospitalization; Humans; Indans; Male; Memantine; Middle Aged; Piperidines; Pneumonia; Risk; Rivastigmine	2017
Cholinergic activation affects the acute and chronic antinociceptive effects of morphine. Physiology & behavior, 2017, 02-01, Volume: 169 Topics: Acetylcholine; Analgesics, Opioid; Analysis of Variance; Animals; Area Under Curve; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Drug Synergism; Indans; Male; Mice; Morphine; Pain; Pain Measurement; Piperidines; Rivastigmine; Time Factors	2017
Therapeutic effects of drug switching between acetylcholinesterase inhibitors in patients with Alzheimer's disease. Geriatrics & gerontology international, 2017, Volume: 17, Issue:11 Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Substitution; Galantamine; Humans; Retrospective Studies; Rivastigmine; Treatment Outcome	2017
Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching. Drugs & aging, 2017, Volume: 34, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Tolerance; Female; Galantamine; Humans; Indans; Male; Medication Adherence; Piperidines; Rivastigmine	2017
Different clinical effect of four antidementia drugs for Alzheimer's disease patients depending on white matter severity. Geriatrics & gerontology international, 2017, Volume: 17, Issue:11 Topics: Activities of Daily Living; Aged; Alzheimer Disease; Donepezil; Female; Galantamine; Humans; Male; Memantine; Nootropic Agents; Rivastigmine; Severity of Illness Index; Treatment Outcome; White Matter	2017
Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2017, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Asian People; Cholinergic Antagonists; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Hawaii; Hospitals, Urban; Humans; Indans; Male; Memantine; Native Hawaiian or Other Pacific Islander; Pacific Islands; Piperidines; Retrospective Studies; Rivastigmine	2017
Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies. Journal of molecular graphics & modelling, 2017, Volume: 76 Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Hydrogen Bonding; Indans; Molecular Conformation; Molecular Dynamics Simulation; Piperidines; Rivastigmine; Torpedo	2017
Utilization of Western medicine and traditional Chinese medicine among patients with Alzheimer's disease in Taiwan: a nationwide population-based study. European journal of neurology, 2017, Volume: 24, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drugs, Chinese Herbal; Female; Humans; Indans; Male; Medicine, Chinese Traditional; Middle Aged; Piperidines; Rivastigmine; Sex Factors; Taiwan; Time-to-Treatment; Urbanization	2017
A chiral enantioseparation generic strategy for anti-Alzheimer and antifungal drugs by short end injection capillary electrophoresis using an experimental design approach. Chirality, 2018, Volume: 30, Issue:2 Topics: Alzheimer Disease; Antifungal Agents; Cyclodextrins; Donepezil; Electrophoresis, Capillary; Indans; Injections; Piperidines; Rivastigmine; Stereoisomerism	2018
Simple determination of some antidementia drugs in wastewater and human plasma samples by tandem dispersive liquid-liquid microextraction followed by high-performance liquid chromatography. Journal of separation science, 2018, Volume: 41, Issue:10 Topics: Algorithms; Calibration; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Donepezil; Humans; Hydrogen-Ion Concentration; Indans; Limit of Detection; Linear Models; Liquid Phase Microextraction; Neuroprotective Agents; Piperidines; Plasma; Reproducibility of Results; Rivastigmine; Salts; Solvents; Wastewater	2018
Safety and Efficacy of Anti-dementia Agents in the Extremely Elderly Patients with Dementia. Journal of Korean medical science, 2018, May-07, Volume: 33, Issue:19 Topics: Activities of Daily Living; Aged, 80 and over; Alzheimer Disease; Donepezil; Exanthema; Female; Humans; Indans; Male; Medication Adherence; Nausea; Neuropsychological Tests; Nootropic Agents; Piperidines; Retrospective Studies; Rivastigmine; Treatment Outcome	2018
The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease. American journal of Alzheimer's disease and other dementias, 2018, Volume: 33, Issue:6 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Longitudinal Studies; Male; Models, Statistical; Mortality; Rivastigmine; Time Factors	2018
Effect of acetylcholinesterase inhibitors donepezil and rivastigmine on the activity and expression of cyclooxygenases in a model of the inflammatory action of fluoride on macrophages obtained from THP-1 monocytes. Toxicology, 2018, 08-01, Volume: 406-407 Topics: Cholinesterase Inhibitors; Cyclooxygenase 1; Cyclooxygenase 2; Donepezil; Fluorides; Gene Expression Regulation, Enzymologic; Humans; Macrophages; Monocytes; Rivastigmine; THP-1 Cells	2018
Influence of Acetylcholinesterase Inhibitors Used in Alzheimer's Disease Treatment on the Activity of Antioxidant Enzymes and the Concentration of Glutathione in International journal of environmental research and public health, 2018, 12-20, Volume: 16, Issue:1 Topics: Alzheimer Disease; Antioxidants; Cholinesterase Inhibitors; Donepezil; Fluorides; Glutathione; Humans; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Rivastigmine; THP-1 Cells	2018
Anticholinergic medicines use among older adults before and after initiating dementia medicines. British journal of clinical pharmacology, 2019, Volume: 85, Issue:9 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Australia; Cholinergic Antagonists; Cholinesterase Inhibitors; Dementia; Deprescriptions; Donepezil; Drug Prescriptions; Female; Humans; Male; Memantine; Middle Aged; Retrospective Studies; Risperidone; Rivastigmine	2019
Effect of CYP2D6 and CYP3A4 Genotypes on the Efficacy of Cholinesterase Inhibitors in Southern Chinese Patients With Alzheimer's Disease. American journal of Alzheimer's disease and other dementias, 2019, Volume: 34, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Donepezil; Female; Follow-Up Studies; Galantamine; Genotype; Hong Kong; Humans; Male; Pharmacogenetics; Pharmacogenomic Testing; Rivastigmine	2019
[Patterns of antidemential drug use in a group of patients from Colombia]. Revista de neurologia, 2019, May-16, Volume: 68, Issue:10 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Colombia; Cross-Sectional Studies; Dementia; Donepezil; Drug Utilization; Female; Galantamine; Humans; Male; Memantine; Middle Aged; Receptors, N-Methyl-D-Aspartate; Rivastigmine	2019
Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model. Cardiovascular toxicology, 2020, Volume: 20, Issue:2 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiotoxicity; Cholinesterase Inhibitors; Donepezil; Galantamine; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Rabbits; Refractory Period, Electrophysiological; Risk Assessment; Rivastigmine; Time Factors	2020
One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland. Journal of Alzheimer's disease : JAD, 2019, Volume: 70, Issue:3 Topics: Aged; Alzheimer Disease; Donepezil; Drug Utilization Review; Female; Humans; Male; Medication Adherence; Memantine; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care; Poland; Practice Patterns, Physicians'; Rivastigmine	2019
Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2019, Sep-16, Volume: 191, Issue:37 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Hospitalization; Humans; Male; Ontario; Retrospective Studies; Rhabdomyolysis; Risk Assessment; Rivastigmine	2019
Cholinesterase as a Target for Drug Development in Alzheimer's Disease. Methods in molecular biology (Clifton, N.J.), 2020, Volume: 2089 Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Drug Development; Galantamine; Humans; Memantine; Rivastigmine	2020
Medical interventions suppressed progression of advanced Alzheimer's disease more than mild Alzheimer's disease. Geriatrics & gerontology international, 2020, Volume: 20, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Disease Progression; Donepezil; Female; Galantamine; Humans; Japan; Male; Memantine; Mental Status and Dementia Tests; Retrospective Studies; Rivastigmine	2020
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy. Biomolecules, 2020, 05-20, Volume: 10, Issue:5 Topics: Binding Sites; Cholinesterase Inhibitors; Donepezil; Humans; Molecular Docking Simulation; Nootropic Agents; Protein Binding; Protein Kinase Inhibitors; Rivastigmine; RNA Helicases	2020
Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities. Journal of Alzheimer's disease : JAD, 2020, Volume: 76, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Dopamine Agents; Female; Galantamine; Healthcare Disparities; Humans; Male; Medicare; Memantine; Nootropic Agents; Patient Acceptance of Health Care; Rivastigmine; Treatment Outcome; United States	2020
Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil. Drug design, development and therapy, 2020, Volume: 14 Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Chromatography, Liquid; Cytochrome P-450 CYP2D6; Donepezil; Drug Monitoring; Female; Genotype; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Rivastigmine; Tandem Mass Spectrometry	2020
Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors. Current neuropharmacology, 2021, Volume: 19, Issue:8 Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Donepezil; Galantamine; Rivastigmine; Tacrine	2021
Post-market utilization patterns of Alzheimer's disease treatments in South Korea: comparison with countries with universal health coverage. European journal of clinical pharmacology, 2021, Volume: 77, Issue:6 Topics: Alzheimer Disease; Australia; Cholinesterase Inhibitors; Donepezil; Galantamine; Global Health; Humans; Memantine; Product Surveillance, Postmarketing; Republic of Korea; Rivastigmine; Universal Health Care	2021
Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer's Disease Patients: A Finnish Nationwide Cohort Study. Journal of Alzheimer's disease : JAD, 2021, Volume: 81, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cohort Studies; Donepezil; Female; Finland; Galantamine; Humans; Male; Memantine; Nootropic Agents; Nursing Homes; Retrospective Studies; Rivastigmine; Time-to-Treatment	2021
Multiple cholinesterase inhibitors have antidepressant-like properties in the mouse forced swim test. Behavioural brain research, 2021, 07-09, Volume: 409 Topics: Animals; Antidepressive Agents; Association Learning; Behavior, Animal; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Repositioning; Galantamine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Physostigmine; Rivastigmine; Swimming	2021
Microsequential injection analysis/lab-on-valve system for the automatic evaluation of acetylcholinesterase inhibitors. Archiv der Pharmazie, 2021, Volume: 354, Issue:10 Topics: Animals; Cholinesterase Inhibitors; Donepezil; Electrophorus; Flow Injection Analysis; Galantamine; Humans; Molecular Docking Simulation; Reproducibility of Results; Rivastigmine; Structure-Activity Relationship; Xanthones	2021
The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System. Journal of Alzheimer's disease : JAD, 2021, Volume: 83, Issue:3 Topics: Adverse Drug Reaction Reporting Systems; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Databases, Factual; Donepezil; Female; Galantamine; Humans; Male; Nootropic Agents; Pneumonia; Rivastigmine; Sex Factors; United States; United States Food and Drug Administration	2021
Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling. International journal of molecular sciences, 2021, Sep-30, Volume: 22, Issue:19 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Cells, Cultured; Cholinesterase Inhibitors; Cytokines; Disease Models, Animal; Donepezil; Inflammasomes; Inflammation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mitogen-Activated Protein Kinases; NLR Family, Pyrin Domain-Containing 3 Protein; Rivastigmine; STAT3 Transcription Factor	2021
Risk of overactive bladder associated with cholinesterase inhibitors in dementia. Journal of the American Geriatrics Society, 2022, Volume: 70, Issue:3 Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Galantamine; Humans; Male; Medicare; Muscarinic Antagonists; Retrospective Studies; Rivastigmine; United States; Urinary Bladder, Overactive	2022
Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM. Scientific reports, 2022, 03-15, Volume: 12, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Rivastigmine	2022
Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study. Journal of Alzheimer's disease : JAD, 2022, Volume: 87, Issue:3 Topics: Aged; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cohort Studies; Donepezil; Humans; Retrospective Studies; Rivastigmine	2022
First Donepezil Transdermal Patch Approved for Alzheimer Disease. JAMA, 2022, 05-03, Volume: 327, Issue:17 Topics: Administration, Cutaneous; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Nootropic Agents; Rivastigmine; Transdermal Patch	2022
Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study. Drugs & aging, 2022, Volume: 39, Issue:6 Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cohort Studies; Donepezil; Female; Galantamine; Humans; Indans; Male; Medicare; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; United States	2022
Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies. Bioorganic chemistry, 2022, Volume: 127 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Chalcone; Chalcones; Chalones; Cholinesterase Inhibitors; Donepezil; Drug Design; Neuroprotective Agents; Positron Emission Tomography Computed Tomography; Rats; Rivastigmine; Structure-Activity Relationship	2022
Corpus callosum anatomical changes in Alzheimer patients and the effect of acetylcholinesterase inhibitors on corpus callosum morphometry. PloS one, 2022, Volume: 17, Issue:7 Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Corpus Callosum; Donepezil; Female; Humans; Magnetic Resonance Imaging; Male; Rivastigmine	2022
Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System. Journal of Alzheimer's disease : JAD, 2022, Volume: 89, Issue:2 Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; Donepezil; Galantamine; Humans; Memantine; Penicillamine; Risk Management; Rivastigmine; United States; United States Food and Drug Administration	2022
Phytochemicals-based Therapeutics against Alzheimer's Disease: An Update. Current topics in medicinal chemistry, 2022, Volume: 22, Issue:22 Topics: Alzheimer Disease; Amyloid beta-Peptides; Donepezil; Humans; Phytochemicals; Quality of Life; Rivastigmine	2022
Anti-dementia medication use in Aotearoa New Zealand: An exploratory study using health data from the Integrated Data Infrastructure (IDI). The Australian and New Zealand journal of psychiatry, 2023, Volume: 57, Issue:6 Topics: Acetylcholinesterase; African People; Aged; Aged, 80 and over; Asian; Donepezil; European People; Female; Hispanic or Latino; Humans; Male; Maori People; Middle Aged; Middle Eastern People; Native Hawaiian or Other Pacific Islander; New Zealand; Pacific Island People; Retrospective Studies; Rivastigmine	2023
Real-world effects of anti-dementia treatment on mortality in patients with Alzheimer´s dementia. Medicine, 2022, Nov-11, Volume: 101, Issue:45 Topics: Alzheimer Disease; Donepezil; Female; Galantamine; Humans; Indans; Male; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine	2022
Usmarapride (SUVN-D4010), a 5-HT European journal of pharmacology, 2023, May-15, Volume: 947 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Donepezil; Rats; Rivastigmine; Serotonin	2023
Adverse Drug Event Profile Associated with Anti-dementia Drugs: Analysis of a Spontaneous Reporting Database. Die Pharmazie, 2023, 05-01, Volume: 78, Issue:5 Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Donepezil; Drug-Related Side Effects and Adverse Reactions; Galantamine; Humans; Indans; Memantine; Piperidines; Rivastigmine	2023
Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorption. Journal of cellular physiology, 2023, Volume: 238, Issue:8 Topics: Acetylcholinesterase; Animals; Bone Resorption; Cell Differentiation; Cholinesterase Inhibitors; Donepezil; Female; Humans; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand; Rivastigmine; Transcription Factors; X-Ray Microtomography	2023
Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease. Journal of enzyme inhibition and medicinal chemistry, 2023, Volume: 38, Issue:1 Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Neuroprotective Agents; Rivastigmine; Structure-Activity Relationship	2023
Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact. Alzheimer's research & therapy, 2023, 08-03, Volume: 15, Issue:1 Topics: Alzheimer Disease; Cholinesterase Inhibitors; COVID-19; Donepezil; Female; Galantamine; Humans; Indans; Male; Memantine; Pandemics; Phenylcarbamates; Piperidines; Prevalence; Retrospective Studies; Rivastigmine	2023